BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;292:G518-25. [DOI: 10.1152/ajpgi.00024.2006] [Cited by in Crossref: 534] [Cited by in F6Publishing: 531] [Article Influence: 35.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Zhou J, Zhang Y, Tang J, Sun B, Xu W, Wang X, Chen Y, Sun Z. Changes in Intestinal Microbiota Are Associated with Islet Function in a Mouse Model of Dietary Vitamin A Deficiency. J Diabetes Res 2020;2020:2354108. [PMID: 32064275 DOI: 10.1155/2020/2354108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Khalifeh M, Awaisheh S, Alameri O, Hananeh W. Small intestine mucosal immune system response to high-fat-high-cholesterol dietary supplementation in male rats. Food and Agricultural Immunology 2014;26:293-304. [DOI: 10.1080/09540105.2014.914467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Caricilli AM, Saad MJ. The role of gut microbiota on insulin resistance. Nutrients 2013;5:829-51. [PMID: 23482058 DOI: 10.3390/nu5030829] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 12.1] [Reference Citation Analysis]
4 Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol. 2011;110:650-657. [PMID: 21281408 DOI: 10.1111/j.1365-2672.2010.04922.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 12.7] [Reference Citation Analysis]
5 Patel PN, Shah RY, Ferguson JF, Reilly MP. Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases. Arterioscler Thromb Vasc Biol 2015;35:525-34. [PMID: 25550206 DOI: 10.1161/ATVBAHA.114.304455] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
6 Xu S, Dou Y, Ye B, Wu Q, Wang Y, Hu M, Ma F, Rong X, Guo J. Ganoderma lucidum polysaccharides improve insulin sensitivity by regulating inflammatory cytokines and gut microbiota composition in mice. Journal of Functional Foods 2017;38:545-52. [DOI: 10.1016/j.jff.2017.09.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
7 Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes. 2014;5:3-17. [PMID: 23886976 DOI: 10.3920/bm2012.0065] [Cited by in Crossref: 159] [Cited by in F6Publishing: 83] [Article Influence: 19.9] [Reference Citation Analysis]
8 Li H, Lelliott C, Håkansson P, Ploj K, Tuneld A, Verolin-johansson M, Benthem L, Carlsson B, Storlien L, Michaëlsson E. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism 2008;57:1704-10. [DOI: 10.1016/j.metabol.2008.07.029] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
9 Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab 2007;3:458-69. [PMID: 17515890 DOI: 10.1038/ncpendmet0505] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
10 Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology. 2009;137:1467-1477.e5. [PMID: 19549522 DOI: 10.1053/j.gastro.2009.06.045] [Cited by in Crossref: 120] [Cited by in F6Publishing: 127] [Article Influence: 9.2] [Reference Citation Analysis]
11 Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87. [DOI: 10.1002/hep.22848] [Cited by in Crossref: 785] [Cited by in F6Publishing: 768] [Article Influence: 60.4] [Reference Citation Analysis]
12 Hyland NP, Chambers AP, Keenan CM, Pittman QJ, Sharkey KA. Differential adipokine response in genetically predisposed lean and obese rats during inflammation: a role in modulating experimental colitis? Am J Physiol Gastrointest Liver Physiol 2009;297:G869-77. [PMID: 20501435 DOI: 10.1152/ajpgi.00164.2009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
13 Kesar V, Odin JA. Toll-like receptors and liver disease. Liver Int 2014;34:184-96. [DOI: 10.1111/liv.12315] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
14 Price TR, Baskaran SA, Moncada KL, Minamoto Y, Klemashevich C, Jayuraman A, Sucholdoski JS, Tedeschi LO, Steiner JM, Pillai SD, Walzem RL. Whole and Isolated Protein Fractions Differentially Affect Gastrointestinal Integrity Markers in C57Bl/6 Mice Fed Diets with a Moderate-Fat Content. Nutrients 2021;13:1251. [PMID: 33920187 DOI: 10.3390/nu13041251] [Reference Citation Analysis]
15 Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr 2020;123:1127-37. [PMID: 32008579 DOI: 10.1017/S0007114520000380] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
16 Keskitalo A, Munukka E, Toivonen R, Hollmén M, Kainulainen H, Huovinen P, Jalkanen S, Pekkala S. Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice. PLoS One 2018;13:e0198262. [PMID: 29847581 DOI: 10.1371/journal.pone.0198262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
17 Cai J, Zhang XJ, Li H. Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease. Trends Endocrinol Metab 2018;29:712-22. [PMID: 30131212 DOI: 10.1016/j.tem.2018.08.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
18 Duan M, Liu F, Fu H, Feng S, Wang X, Wang T. Effect of Ulinastatin on Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Systemic Review and Meta-Analysis. Front Neurosci 2021;15:618589. [PMID: 34248475 DOI: 10.3389/fnins.2021.618589] [Reference Citation Analysis]
19 Nakao T, Kurita N, Komatsu M, Yoshikawa K, Iwata T, Utusnomiya T, Shimada M. Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res. 2012;173:341-347. [PMID: 21176921 DOI: 10.1016/j.jss.2010.10.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
20 Zhang H, Zhang E, Hu H. Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies. Biomedicines 2021;9:1660. [PMID: 34829889 DOI: 10.3390/biomedicines9111660] [Reference Citation Analysis]
21 Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-2383. [PMID: 17823788 DOI: 10.1007/s00125-007-0791-0] [Cited by in Crossref: 1080] [Cited by in F6Publishing: 989] [Article Influence: 72.0] [Reference Citation Analysis]
22 Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091-1103. [PMID: 19240062 DOI: 10.1136/gut.2008.165886] [Cited by in Crossref: 1478] [Cited by in F6Publishing: 1379] [Article Influence: 113.7] [Reference Citation Analysis]
23 Kurita N, Yamashiro K, Kuroki T, Tanaka R, Urabe T, Ueno Y, Miyamoto N, Takanashi M, Shimura H, Inaba T, Yamashiro Y, Nomoto K, Matsumoto S, Takahashi T, Tsuji H, Asahara T, Hattori N. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia. J Cereb Blood Flow Metab 2020;40:2505-20. [PMID: 31910709 DOI: 10.1177/0271678X19899577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Manco M, Putignani L, Bottazzo GF. Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk. Endocrine Reviews 2010;31:817-44. [DOI: 10.1210/er.2009-0030] [Cited by in Crossref: 268] [Cited by in F6Publishing: 262] [Article Influence: 22.3] [Reference Citation Analysis]
25 Bertiaux-vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi A, Déchelotte P, Ménard J, Ducrotté P, Coëffier M. The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype. American Journal of Gastroenterology 2011;106:2165-73. [DOI: 10.1038/ajg.2011.257] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 14.4] [Reference Citation Analysis]
26 Kim A. Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2015;49:S20-4. [DOI: 10.1097/mcg.0000000000000356] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Osbak PS, Bindslev N, Hansen MB. Relationships between body mass index and short-circuit current in human duodenal and colonic mucosal biopsies. Acta Physiol (Oxf) 2011;201:47-53. [PMID: 20950341 DOI: 10.1111/j.1748-1716.2010.02202.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
28 Ritze Y, Bárdos G, Hubert A, Böhle M, Bischoff SC. Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice. Br J Nutr 2014;112:1-7. [PMID: 24708895 DOI: 10.1017/S0007114514000440] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
29 Sawada Y, Kawaratani H, Kubo T, Fujinaga Y, Furukawa M, Saikawa S, Sato S, Seki K, Takaya H, Okura Y, Kaji K, Shimozato N, Mashitani T, Kitade M, Moriya K, Namisaki T, Akahane T, Mitoro A, Yamao J, Yoshiji H. Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis. Hepatol Res 2018;49:284-95. [DOI: 10.1111/hepr.13281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
30 Plovier H, Cani PD, Britton RA, Cani PD. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders? Microbiol Spectr 2017;5. [DOI: 10.1128/microbiolspec.bad-0002-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
31 Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
32 Guo Y, Mah E, Bruno RS. Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults. Nutrition 2014;30:1279-86. [DOI: 10.1016/j.nut.2014.03.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
33 Bowser SM, McMillan RP, Boutagy NE, Tarpey MD, Smithson AT, Osterberg KL, Neilson AP, Davy BM, Davy KP, Hulver MW. Serum endotoxin, gut permeability and skeletal muscle metabolic adaptations following a short term high fat diet in humans. Metabolism 2020;103:154041. [PMID: 31785256 DOI: 10.1016/j.metabol.2019.154041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. Int J Mol Sci 2021;22:8161. [PMID: 34360923 DOI: 10.3390/ijms22158161] [Reference Citation Analysis]
35 Rivera CA. Risk factors and mechanisms of non-alcoholic steatohepatitis. Pathophysiology 2008;15:109-14. [PMID: 18667295 DOI: 10.1016/j.pathophys.2008.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
36 Gori M, Altomare A, Cocca S, Solida E, Ribolsi M, Carotti S, Rainer A, Francesconi M, Morini S, Cicala M, Guarino MPL. Palmitic Acid Affects Intestinal Epithelial Barrier Integrity and Permeability In Vitro. Antioxidants (Basel) 2020;9:E417. [PMID: 32414055 DOI: 10.3390/antiox9050417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
38 Xu D, Gao J, Gillilland M, Wu X, Song I, Kao JY, Owyang C. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014;146:484-96.e4. [PMID: 24161699 DOI: 10.1053/j.gastro.2013.10.026] [Cited by in Crossref: 146] [Cited by in F6Publishing: 135] [Article Influence: 16.2] [Reference Citation Analysis]
39 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
40 Kessoku T, Kobayashi T, Imajo K, Tanaka K, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Nogami A, Honda Y, Ogawa Y, Kato S, Higurashi T, Hosono K, Yoneda M, Okamoto T, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A. Endotoxins and Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:770986. [PMID: 34777261 DOI: 10.3389/fendo.2021.770986] [Reference Citation Analysis]
41 Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol Ther. 2011;130:202-212. [PMID: 21295072 DOI: 10.1016/j.pharmthera.2011.01.012] [Cited by in Crossref: 220] [Cited by in F6Publishing: 185] [Article Influence: 20.0] [Reference Citation Analysis]
42 Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299:E685-E694. [PMID: 20823452 DOI: 10.1152/ajpendo.00283.2010] [Cited by in Crossref: 249] [Cited by in F6Publishing: 225] [Article Influence: 20.8] [Reference Citation Analysis]
43 Roh YS, Kim JW, Park S, Shon C, Kim S, Eo SK, Kwon JK, Lim CW, Kim B. Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice. The American Journal of Pathology 2018;188:2574-88. [DOI: 10.1016/j.ajpath.2018.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
44 Madan R, Guo X, Naylor C, Buonomo EL, Mackay D, Noor Z, Concannon P, Scully KW, Pramoonjago P, Kolling GL, Warren CA, Duggal P, Petri WA Jr. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun 2014;82:341-9. [PMID: 24166957 DOI: 10.1128/IAI.00972-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
45 Rana D, Duseja A, Dhiman RK, Chawla Y, Arora SK. Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin. Hepatol Int 2013;7:562-9. [DOI: 10.1007/s12072-012-9371-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Wang X, Zhang Z, Zheng G, Wang A, Sun C, Qin S, Zhuang J, Lu J, Ma D, Zheng Y. Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet–treated mice. Appl Physiol Nutr Metab 2017;42:1082-91. [DOI: 10.1139/apnm-2016-0635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
47 Kumar SA, Ward LC, Brown L. Inulin oligofructose attenuates metabolic syndrome in high-carbohydrate, high-fat diet-fed rats. Br J Nutr 2016;116:1502-11. [PMID: 27805541 DOI: 10.1017/S0007114516003627] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
48 Knaapen M, Kootte R, Zoetendal E, de Vos W, Dallinga-thie G, Levi M, Stroes E, Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical Microbiology and Infection 2013;19:331-7. [DOI: 10.1111/1469-0691.12170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
49 Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645-649. [PMID: 20400911 DOI: 10.1097/mpg.0b013e3181c7bdf1] [Cited by in Crossref: 96] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
50 Zhang Y, Shao F, Guan Z, Luo J, Xiao X, Zhou L. Overexpression of miR-99a Alleviates Intestinal Mucosal Barrier Injury in Rats with Severe Acute Pancreatitis. J Interferon Cytokine Res 2021;41:72-80. [PMID: 33621134 DOI: 10.1089/jir.2020.0085] [Reference Citation Analysis]
51 Liu B, Zhang J, Sun P, Yi R, Han X, Zhao X. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. Biomolecules. 2019;9. [PMID: 31480575 DOI: 10.3390/biom9090435] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
52 Li CC, Liu C, Fu M, Hu KQ, Aizawa K, Takahashi S, Hiroyuki S, Cheng J, von Lintig J, Wang XD. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Mol Nutr Food Res 2018;62:e1700738. [PMID: 29266812 DOI: 10.1002/mnfr.201700738] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
53 Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos WM, Mengheri E. The Novel Porcine Lactobacillus sobrius Strain Protects Intestinal Cells from Enterotoxigenic Escherichia coli K88 Infection and Prevents Membrane Barrier Damage. The Journal of Nutrition 2007;137:2709-16. [DOI: 10.1093/jn/137.12.2709] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 6.7] [Reference Citation Analysis]
54 Grams J, Garvey WT. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep 2015;4:287-302. [PMID: 26627223 DOI: 10.1007/s13679-015-0155-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
55 Cadamuro M, Lasagni A, Sarcognato S, Guido M, Fabris R, Strazzabosco M, Strain AJ, Simioni P, Villa E, Fabris L. The Neglected Role of Bile Duct Epithelial Cells in NASH. Semin Liver Dis 2021. [PMID: 34794182 DOI: 10.1055/s-0041-1739455] [Reference Citation Analysis]
56 Do TT, Hindlet P, Waligora-Dupriet AJ, Kapel N, Neveux N, Mignon V, Deloménie C, Farinotti R, Fève B, Buyse M. Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance. Am J Physiol Endocrinol Metab. 2014;306:E668-E680. [PMID: 24425764 DOI: 10.1152/ajpendo.00437.2013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
57 Roncon-Albuquerque R Jr, Moreira-Rodrigues M, Faria B, Ferreira AP, Cerqueira C, Lourenço AP, Pestana M, von Hafe P, Leite-Moreira AF. Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice. Life Sci 2008;83:502-10. [PMID: 18761356 DOI: 10.1016/j.lfs.2008.07.021] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
58 Nychyk O, Barton W, Rudolf AM, Boscaini S, Walsh A, Bastiaanssen TFS, Giblin L, Cormican P, Chen L, Piotrowicz Y, Derous D, Fanning Á, Yin X, Grant J, Melgar S, Brennan L, Mitchell SE, Cryan JF, Wang J, Cotter PD, Speakman JR, Nilaweera KN. Protein quality and quantity influence the effect of dietary fat on weight gain and tissue partitioning via host-microbiota changes. Cell Rep 2021;35:109093. [PMID: 33979605 DOI: 10.1016/j.celrep.2021.109093] [Reference Citation Analysis]
59 Duarte SMB, Stefano JT, Oliveira CP. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Ann Hepatol 2019;18:416-21. [PMID: 31036494 DOI: 10.1016/j.aohep.2019.04.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
60 Chi ZC. Pathogenesis of non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2017; 25(8): 670-683 [DOI: 10.11569/wcjd.v25.i8.670] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front Microbiol 2018;9:61. [PMID: 29441049 DOI: 10.3389/fmicb.2018.00061] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 16.0] [Reference Citation Analysis]
62 Luo Q, Cheng D, Huang C, Li Y, Lao C, Xia Y, Liu W, Gong X, Hu D, Li B, He X, Chen Z. Improvement of Colonic Immune Function with Soy Isoflavones in High-Fat Diet-Induced Obese Rats. Molecules. 2019;24. [PMID: 30909396 DOI: 10.3390/molecules24061139] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
63 Su YB, Li TH, Huang CC, Tsai HC, Huang SF, Hsieh YC, Yang YY, Huang YH, Hou MC, Lin HC. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. PLoS One 2018;13:e0194867. [PMID: 29684027 DOI: 10.1371/journal.pone.0194867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
64 Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103:71-83. [PMID: 19914930 DOI: 10.1093/qjmed/hcp158] [Cited by in Crossref: 392] [Cited by in F6Publishing: 366] [Article Influence: 30.2] [Reference Citation Analysis]
65 Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008;180:5653-5661. [PMID: 18390750 DOI: 10.4049/jimmunol.180.8.5653] [Cited by in Crossref: 245] [Cited by in F6Publishing: 236] [Article Influence: 17.5] [Reference Citation Analysis]
66 Swallah MS, Fan H, Wang S, Yu H, Piao C. Prebiotic Impacts of Soybean Residue (Okara) on Eubiosis/Dysbiosis Condition of the Gut and the Possible Effects on Liver and Kidney Functions. Molecules 2021;26:E326. [PMID: 33440603 DOI: 10.3390/molecules26020326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
67 Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. Gastroenterol Hepatol 2018;41:328-49. [PMID: 29631866 DOI: 10.1016/j.gastrohep.2017.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
68 Andriessen EM, Wilson AM, Mawambo G, Dejda A, Miloudi K, Sennlaub F, Sapieha P. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med 2016;8:1366-79. [PMID: 27861126 DOI: 10.15252/emmm.201606531] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
69 Guzylack-Piriou L, Ménard S. Early Life Exposure to Food Contaminants and Social Stress as Risk Factor for Metabolic Disorders Occurrence?-An Overview. Biomolecules 2021;11:687. [PMID: 34063694 DOI: 10.3390/biom11050687] [Reference Citation Analysis]
70 Ritchie RH, Abel ED. Basic Mechanisms of Diabetic Heart Disease. Circ Res 2020;126:1501-25. [PMID: 32437308 DOI: 10.1161/CIRCRESAHA.120.315913] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 22.5] [Reference Citation Analysis]
71 Land Lail H, Feresin RG, Hicks D, Stone B, Price E, Wanders D. Berries as a Treatment for Obesity-Induced Inflammation: Evidence from Preclinical Models. Nutrients 2021;13:334. [PMID: 33498671 DOI: 10.3390/nu13020334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One. 2013;8:e63983. [PMID: 23704966 DOI: 10.1371/journal.pone.0063983] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
73 Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6:7489. [PMID: 26102296 DOI: 10.1038/ncomms8489] [Cited by in Crossref: 503] [Cited by in F6Publishing: 477] [Article Influence: 71.9] [Reference Citation Analysis]
74 Sharifnia T, Antoun J, Verriere TG, Suarez G, Wattacheril J, Wilson KT, Peek RM, Abumrad NN, Flynn CR. Hepatic TLR4 signaling in obese NAFLD. Am J Physiol Gastrointest Liver Physiol. 2015;309:G270-G278. [PMID: 26113297 DOI: 10.1152/ajpgi.00304.2014.Epub] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Kiziltas S, Ata P, Colak Y, Mesçi B, Senates E, Enc F, Ulasoglu C, Tuncer I, Oguz A. TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 2014;12:165-170. [PMID: 24443993 DOI: 10.1089/met.2013.0120] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
76 Cheng C, Tan J, Qian W, Zhang L, Hou X. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. Life Sci. 2018;209:157-166. [PMID: 30096384 DOI: 10.1016/j.lfs.2018.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
77 Brun P, Piovan A, Caniato R, Dalla Costa V, Pauletto A, Filippini R. Anti-Inflammatory Activities of Euglena gracilis Extracts. Microorganisms 2021;9:2058. [PMID: 34683379 DOI: 10.3390/microorganisms9102058] [Reference Citation Analysis]
78 Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009;94:261-267. [PMID: 18984670 DOI: 10.1210/jc.2007-2579] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
79 Chu H, Williams B, Schnabl B. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Res. 2018;2:43-51. [PMID: 30416839 DOI: 10.1016/j.livres.2017.11.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
80 Singh RK, Wheildon N, Ishikawa S. Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction. SOJ Microbiol Infect Dis 2016;4. [PMID: 27430014 DOI: 10.15226/sojmid/4/1/00148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
81 Penrose HM, Heller S, Cable C, Nakhoul H, Baddoo M, Flemington E, Crawford SE, Savkovic SD. High-fat diet induced leptin and Wnt expression: RNA-sequencing and pathway analysis of mouse colonic tissue and tumors. Carcinogenesis 2017;38:302-11. [PMID: 28426873 DOI: 10.1093/carcin/bgx001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
82 Belei O, Olariu L, Dobrescu A, Marcovici T, Marginean O. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents. J Pediatr Endocrinol Metab 2017;30:1161-8. [PMID: 28988228 DOI: 10.1515/jpem-2017-0252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
83 Moludi J, Maleki V, Jafari‐vayghyan H, Vaghef‐mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol 2020;47:927-39. [DOI: 10.1111/1440-1681.13250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
84 Sanchez M, Panahi S, Tremblay A. Childhood obesity: a role for gut microbiota? Int J Environ Res Public Health. 2015;12:162-175. [PMID: 25546278 DOI: 10.3390/ijerph120100162] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
85 Zhou X, Han D, Xu R, Li S, Wu H, Qu C, Wang F, Wang X, Zhao Y. A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. PLoS One. 2014;9:e115148. [PMID: 25502558 DOI: 10.1371/journal.pone.0115148] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
86 Hulston CJ, Churnside AA, Venables MC. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 2015;113:596-602. [PMID: 25630516 DOI: 10.1017/S0007114514004097] [Cited by in Crossref: 79] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
87 Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Am J Physiol Gastrointest Liver Physiol 2020;318:G889-906. [PMID: 32146836 DOI: 10.1152/ajpgi.00161.2019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
88 Hodin CM, Verdam FJ, Grootjans J, Rensen SS, Verheyen FK, Dejong CH, Buurman WA, Greve JW, Lenaerts K. Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. J Pathol. 2011;225:276-284. [PMID: 21630271 DOI: 10.1002/path.2917] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
89 Massier L, Blüher M, Kovacs P, Chakaroun RM. Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases. Front Endocrinol (Lausanne) 2021;12:616506. [PMID: 33767669 DOI: 10.3389/fendo.2021.616506] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
90 Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, Delzenne NM, Schrenzel J, Cani PD. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011;60:2775-86. [PMID: 21933985 DOI: 10.2337/db11-0227] [Cited by in Crossref: 603] [Cited by in F6Publishing: 548] [Article Influence: 54.8] [Reference Citation Analysis]
91 Tehrani AB, Nezami BG, Gewirtz A, Srinivasan S. Obesity and its associated disease: a role for microbiota? Neurogastroenterol Motil 2012;24:305-11. [PMID: 22339979 DOI: 10.1111/j.1365-2982.2012.01895.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
92 Cui Y, Wang Q, Chang R, Zhou X, Xu C. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. J Agric Food Chem. 2019;67:2754-2762. [PMID: 30798598 DOI: 10.1021/acs.jafc.9b00080] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
93 Schneier AT, Citti CC, Dieterich DT. Management and diagnosis of fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015;9:671-683. [PMID: 25716275 DOI: 10.1586/17474124.2015.1003209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
94 Lee JW, Park JH, Park DIL, Park J, Kim HJ, Cho YK, Sohn CIL, Jeon WK, Kim BI. Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase. Dig Dis Sci 2010;55:2922-8. [DOI: 10.1007/s10620-009-1094-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
95 Petrasek J, Csak T, Ganz M, Szabo G. Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2013;28 Suppl 1:93-8. [PMID: 23855302 DOI: 10.1111/jgh.12020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
96 Hsieh PS, Chan JY, Shyu JF, Chen YT, Loh CH. Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic beta-cell dysfunction in rats. Eur J Clin Invest. 2008;38:640-648. [PMID: 18837740 DOI: 10.1111/j.1365-2362.2008.01991.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
97 Tappouni R, Mathew P, Connelly TM, Luke F, Messaris E. Measurement of visceral fat on preoperative computed tomography predicts complications after sigmoid colectomy for diverticular disease. The American Journal of Surgery 2015;210:285-90. [DOI: 10.1016/j.amjsurg.2014.10.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
98 Winer DA, Luck H, Tsai S, Winer S. The Intestinal Immune System in Obesity and Insulin Resistance. Cell Metab. 2016;23:413-426. [PMID: 26853748 DOI: 10.1016/j.cmet.2016.01.003] [Cited by in Crossref: 202] [Cited by in F6Publishing: 189] [Article Influence: 33.7] [Reference Citation Analysis]
99 Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol. 2010;24:695-708. [PMID: 20955971 DOI: 10.1016/j.bpg.2010.08.005] [Cited by in Crossref: 128] [Cited by in F6Publishing: 115] [Article Influence: 11.6] [Reference Citation Analysis]
100 Rondanelli M, Miraglia N, Putignano P, Castagliuolo I, Brun P, Dall'Acqua S, Peroni G, Faliva MA, Naso M, Nichetti M, Infantino V, Perna S. Effects of 60-Day Saccharomyces boulardii and Superoxide Dismutase Supplementation on Body Composition, Hunger Sensation, Pro/Antioxidant Ratio, Inflammation and Hormonal Lipo-Metabolic Biomarkers in Obese Adults: A Double-Blind, Placebo-Controlled Trial. Nutrients 2021;13:2512. [PMID: 34444671 DOI: 10.3390/nu13082512] [Reference Citation Analysis]
101 Vázquez-Carrera M. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease. Trends Endocrinol Metab 2016;27:319-34. [PMID: 27005447 DOI: 10.1016/j.tem.2016.02.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
102 Hersoug LG, Møller P, Loft S. Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obes Rev 2016;17:297-312. [PMID: 26712364 DOI: 10.1111/obr.12370] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 15.1] [Reference Citation Analysis]
103 Everard A, Geurts L, Van Roye M, Delzenne NM, Cani PD. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One 2012;7:e33858. [PMID: 22470484 DOI: 10.1371/journal.pone.0033858] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
104 Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obes Rev. 2013;14:950-959. [PMID: 23947604 DOI: 10.1111/obr.12068] [Cited by in Crossref: 129] [Cited by in F6Publishing: 130] [Article Influence: 14.3] [Reference Citation Analysis]
105 Chanda D, Li J, Oligschlaeger Y, Jeurissen ML, Houben T, Walenbergh SM, Shiri-Sverdlov R, Neumann D. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. Exp Mol Med 2016;48:e258. [PMID: 27609031 DOI: 10.1038/emm.2016.79] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
106 Bäckhed F. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the normal gut microbiota in health and disease. Clin Exp Immunol 2010;160:80-4. [PMID: 20415855 DOI: 10.1111/j.1365-2249.2010.04123.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
107 Hsu CC, Ness E, Kowdley KV. Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease. Adv Nutr. 2017;8:253-265. [PMID: 28298270 DOI: 10.3945/an.116.013730] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
108 Bohan R, Tianyu X, Tiantian Z, Ruonan F, Hongtao H, Qiong W, Chao S. Gut microbiota: a potential manipulator for host adipose tissue and energy metabolism. The Journal of Nutritional Biochemistry 2019;64:206-17. [DOI: 10.1016/j.jnutbio.2018.10.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
109 Gruber L, Kisling S, Lichti P, Martin FP, May S, Klingenspor M, Lichtenegger M, Rychlik M, Haller D. High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity. PLoS One 2013;8:e71661. [PMID: 23977107 DOI: 10.1371/journal.pone.0071661] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 7.6] [Reference Citation Analysis]
110 Machado MV, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17:481. [PMID: 27043550 DOI: 10.3390/ijms17040481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
111 Tian YF, He CT, Chen YT, Hsieh PS. Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats. World J Gastroenterol 2013; 19(18): 2761-2771 [PMID: 23687413 DOI: 10.3748/wjg.v19.i18.2761] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
112 Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Adv Nutr 2017;8:240-52. [PMID: 28298269 DOI: 10.3945/an.116.013151] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
113 Dey P, Sasaki GY, Wei P, Li J, Wang L, Zhu J, McTigue D, Yu Z, Bruno RS. Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation. J Nutr Biochem 2019;67:78-89. [PMID: 30856467 DOI: 10.1016/j.jnutbio.2019.01.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
114 Yang R, Xu Y, Dai Z, Lin X, Wang H. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection. J Immunol Res 2018;2018:2361963. [PMID: 30148173 DOI: 10.1155/2018/2361963] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
115 Piya MK, Mcternan PG, Kumar S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. Journal of Endocrinology 2013;216:T1-T15. [DOI: 10.1530/joe-12-0498] [Cited by in Crossref: 140] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
116 Murakami Y, Tanabe S, Suzuki T. High-fat Diet-induced Intestinal Hyperpermeability is Associated with Increased Bile Acids in the Large Intestine of Mice: High-fat diet and intestinal barrier…. Journal of Food Science 2016;81:H216-22. [DOI: 10.1111/1750-3841.13166] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
117 Van Nieuwenhove T, Rasschaert G, Kharagjitsingh A, Keymeulen B, Reynaert H, Kindt S. The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study. Acta Gastroenterol Belg 2021;84:541-7. [PMID: 34965034 DOI: 10.51821/84.4.003] [Reference Citation Analysis]
118 Bruno RS, Pokala A, Torres-Gonzalez M, Blesso CN. Cardiometabolic health benefits of dairy-milk polar lipids. Nutr Rev 2021;79:16-35. [PMID: 34879146 DOI: 10.1093/nutrit/nuab085] [Reference Citation Analysis]
119 Che D, Zhao B, Fan Y, Han R, Zhang C, Qin G, Adams S, Jiang H. Eleutheroside B increase tight junction proteins and anti-inflammatory cytokines expression in intestinal porcine jejunum epithelial cells (IPEC-J2). J Anim Physiol Anim Nutr (Berl) 2019;103:1174-84. [PMID: 30990939 DOI: 10.1111/jpn.13087] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Rapin JR, Wiernsperger N. Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. Clinics (Sao Paulo). 2010;65:635-643. [PMID: 20613941 DOI: 10.1590/s1807-59322010000600012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
121 Efremov L, Lacruz ME, Tiller D, Medenwald D, Greiser KH, Kluttig A, Wienke A, Nuding S, Mikolajczyk R. Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and Inflammatory Biomarkers: Results from the CARLA Study. Diabetes Metab Syndr Obes 2020;13:2653-65. [PMID: 32821138 DOI: 10.2147/DMSO.S263727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139:323-34.e7. [PMID: 20347818 DOI: 10.1053/j.gastro.2010.03.052] [Cited by in Crossref: 452] [Cited by in F6Publishing: 450] [Article Influence: 37.7] [Reference Citation Analysis]
123 Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci 2020;21:E8351. [PMID: 33171747 DOI: 10.3390/ijms21218351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
124 Zhou L, Song XD, Xu H, Liang GQ, Wang F, Zhang LR, Huang F, Cai J, Jiang GR. Exogenous 3-Deoxyglucosone-Induced Carbonyl and Oxidative Stress Causes β-Cells Dysfunction by Impairing Gut Permeability in Rats. Biochemistry Moscow 2018;83:1358-68. [DOI: 10.1134/s0006297918110068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Alam S, Mustafa G, Alam M, Ahmad N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World J Gastrointest Pathophysiol 2016; 7(2): 211-217 [PMID: 27190693 DOI: 10.4291/wjgp.v7.i2.211] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
126 Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol. 2010;298:G335-G344. [PMID: 19713474 DOI: 10.1152/ajpgi.00088.2009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
127 Norris GH, Jiang C, Ryan J, Porter CM, Blesso CN. Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice. The Journal of Nutritional Biochemistry 2016;30:93-101. [DOI: 10.1016/j.jnutbio.2015.12.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
128 Boer CG, Radjabzadeh D, Medina-Gomez C, Garmaeva S, Schiphof D, Arp P, Koet T, Kurilshikov A, Fu J, Ikram MA, Bierma-Zeinstra S, Uitterlinden AG, Kraaij R, Zhernakova A, van Meurs JBJ. Intestinal microbiome composition and its relation to joint pain and inflammation. Nat Commun 2019;10:4881. [PMID: 31653850 DOI: 10.1038/s41467-019-12873-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
129 Suppli MP, Bagger JI, Lelouvier B, Broha A, Demant M, Kønig MJ, Strandberg C, Lund A, Vilsbøll T, Knop FK. Hepatic microbiome in healthy lean and obese humans. JHEP Rep 2021;3:100299. [PMID: 34169247 DOI: 10.1016/j.jhepr.2021.100299] [Reference Citation Analysis]
130 Moran-Ramos S, Baez-Ruiz A, Buijs RM, Escobar C. When to eat? The influence of circadian rhythms on metabolic health: are animal studies providing the evidence? Nutr Res Rev 2016;29:180-93. [PMID: 27364352 DOI: 10.1017/S095442241600010X] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
131 Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2013;14:20704-20728. [PMID: 24132155 DOI: 10.3390/ijms141020704] [Cited by in Crossref: 189] [Cited by in F6Publishing: 182] [Article Influence: 21.0] [Reference Citation Analysis]
132 Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, Bergheim I. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr. 2012;107:1727-1738. [PMID: 22018861 DOI: 10.1017/s0007114511004983] [Cited by in Crossref: 84] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
133 Rios-Arce ND, Collins FL, Schepper JD, Steury MD, Raehtz S, Mallin H, Schoenherr DT, Parameswaran N, McCabe LR. Epithelial Barrier Function in Gut-Bone Signaling. Adv Exp Med Biol 2017;1033:151-83. [PMID: 29101655 DOI: 10.1007/978-3-319-66653-2_8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
134 Nier A, Brandt A, Rajcic D, Bruns T, Bergheim I. Short-Term Isocaloric Intake of a Fructose- but not Glucose-Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects. Mol Nutr Food Res 2019;63:e1800868. [PMID: 30570214 DOI: 10.1002/mnfr.201800868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
135 Aguilar-Valles A, Inoue W, Rummel C, Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacology. 2015;96:124-134. [PMID: 25582291 DOI: 10.1016/j.neuropharm.2014.12.023] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 13.4] [Reference Citation Analysis]
136 Rivera CA, Gaskin L, Allman M, Pang J, Brady K, Adegboyega P, Pruitt K. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis. BMC Gastroenterol. 2010;10:52. [PMID: 20509914 DOI: 10.1186/1471-230x-10-52] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
137 Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
138 Dailey MJ. Nutrient-induced intestinal adaption and its effect in obesity. Physiol Behav 2014;136:74-8. [PMID: 24704111 DOI: 10.1016/j.physbeh.2014.03.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
139 Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y. Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract 2014;106:312-8. [PMID: 25238913 DOI: 10.1016/j.diabres.2014.08.017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
140 Jésus P, Ouelaa W, François M, Riachy L, Guérin C, Aziz M, Do Rego J, Déchelotte P, Fetissov SO, Coëffier M. Alteration of intestinal barrier function during activity-based anorexia in mice. Clinical Nutrition 2014;33:1046-53. [DOI: 10.1016/j.clnu.2013.11.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
141 Carvalho BM, Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm. 2013;2013:986734. [PMID: 23840101 DOI: 10.1155/2013/986734] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
142 Gomez-Santos L, Luka Z, Wagner C, Fernandez-Alvarez S, Lu SC, Mato JM, Martinez-Chantar ML, Beraza N. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase. Hepatology. 2012;56:747-759. [PMID: 22392635 DOI: 10.1002/hep.25694] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
143 Hodges JK, Sasaki GY, Bruno RS. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. J Nutr Biochem 2020;85:108478. [PMID: 32801031 DOI: 10.1016/j.jnutbio.2020.108478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
144 Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, Mcclain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin. Journal of Hepatology 2008;48:983-92. [DOI: 10.1016/j.jhep.2008.01.035] [Cited by in Crossref: 340] [Cited by in F6Publishing: 322] [Article Influence: 24.3] [Reference Citation Analysis]
145 Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol. 2012;303:G32-G41. [PMID: 22538402 DOI: 10.1080/07315724.2012.10720004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
146 Alokail MS, Sabico S, Al-Saleh Y, Al-Daghri NM, Alkharfy KM, Vanhoutte PM, McTernan PG. Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial. Trials. 2013;14:195. [PMID: 23822518 DOI: 10.1186/1745-6215-14-195] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
147 Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb). 2013;23:107-111. [PMID: 23457771 DOI: 10.11613/bm.2013.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
148 Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279-288. [PMID: 22572877 DOI: 10.4161/gmic.19625] [Cited by in Crossref: 431] [Cited by in F6Publishing: 384] [Article Influence: 43.1] [Reference Citation Analysis]
149 Nishimura N, Kaji K, Kitagawa K, Sawada Y, Furukawa M, Ozutsumi T, Fujinaga Y, Tsuji Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Fukui H, Yoshiji H. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. Int J Mol Sci 2021;22:6921. [PMID: 34203178 DOI: 10.3390/ijms22136921] [Reference Citation Analysis]
150 Cui HX, Zhang LS, Luo Y, Yuan K, Huang ZY, Guo Y. A Purified Anthraquinone-Glycoside Preparation From Rhubarb Ameliorates Type 2 Diabetes Mellitus by Modulating the Gut Microbiota and Reducing Inflammation. Front Microbiol 2019;10:1423. [PMID: 31293553 DOI: 10.3389/fmicb.2019.01423] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
151 Hansel C, Erschfeld S, Baues M, Lammers T, Weiskirchen R, Trautwein C, Kroy DC, Drescher HK. The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis. Front Pharmacol 2019;10:244. [PMID: 30949049 DOI: 10.3389/fphar.2019.00244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Al-Sadi R, Guo S, Ye D, Dokladny K, Alhmoud T, Ereifej L, Said HM, Ma TY. Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J Immunol. 2013;190:6596-6606. [PMID: 23656735 DOI: 10.4049/jimmunol.1201876] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
153 Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 2007;47:571-579. [PMID: 17644211 DOI: 10.1016/j.jhrp.2007.04.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Kim MS, Kim JY. Intestinal anti-inflammatory effects of cinnamon extracts in a co-culture model of intestinal epithelial Caco-2 cells and RAW264.7 macrophages. Appl Biol Chem 2017;60:553-61. [DOI: 10.1007/s13765-017-0311-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
155 Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microbial Pathogenesis 2019;137:103774. [DOI: 10.1016/j.micpath.2019.103774] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
156 Carvalho BM, Guadagnini D, Tsukumo DML, Schenka AA, Latuf-Filho P, Vassallo J, Dias JC, Kubota LT, Carvalheira JBC, Saad MJA. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012;55:2823-34. [PMID: 22828956 DOI: 10.1007/s00125-012-2648-4] [Cited by in Crossref: 196] [Cited by in F6Publishing: 177] [Article Influence: 19.6] [Reference Citation Analysis]
157 Swindell WR, Johnston A, Gudjonsson JE. Transcriptional profiles of leukocyte populations provide a tool for interpreting gene expression patterns associated with high fat diet in mice. PLoS One 2010;5:e11861. [PMID: 20686622 DOI: 10.1371/journal.pone.0011861] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
158 Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients 2020;12:E2762. [PMID: 32927776 DOI: 10.3390/nu12092762] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
159 Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017;312:G413-G419. [PMID: 28232456 DOI: 10.1152/ajpgi.00361.2016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
160 Zuo T, Ng SC. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Front Microbiol. 2018;9:2247. [PMID: 30319571 DOI: 10.3389/fmicb.2018.02247] [Cited by in Crossref: 190] [Cited by in F6Publishing: 175] [Article Influence: 47.5] [Reference Citation Analysis]
161 Nackiewicz D, Dan M, He W, Kim R, Salmi A, Rütti S, Westwell-Roper C, Cunningham A, Speck M, Schuster-Klein C, Guardiola B, Maedler K, Ehses JA. TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 2014;57:1645-54. [PMID: 24816367 DOI: 10.1007/s00125-014-3249-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 8.6] [Reference Citation Analysis]
162 Huang Z, Kraus VB. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat Rev Rheumatol 2016;12:123-9. [PMID: 26656661 DOI: 10.1038/nrrheum.2015.158] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 11.3] [Reference Citation Analysis]
163 Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv Nutr 2020;11:77-91. [PMID: 31268137 DOI: 10.1093/advances/nmz061] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 45.0] [Reference Citation Analysis]
164 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Mcleod KH, Richards JL, Yap YA, Mariño E. Dietary Short Chain Fatty Acids: How the Gut Microbiota Fight Against Autoimmune and Inflammatory Diseases. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Elsevier; 2019. pp. 139-59. [DOI: 10.1016/b978-0-12-813820-5.00007-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
166 Woting A, Pfeiffer N, Hanske L, Loh G, Klaus S, Blaut M. Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum. Mol Nutr Food Res 2015;59:2267-78. [PMID: 26202344 DOI: 10.1002/mnfr.201500249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
167 Stenman LK, Holma R, Eggert A, Korpela R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol. 2013;304:G227-G234. [PMID: 23203158 DOI: 10.1152/ajpgi.00267.2012] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 11.1] [Reference Citation Analysis]
168 Bergheim I, Schuppan D. Microbiome and Diseases: Hepatic Disorders. In: Haller D, editor. The Gut Microbiome in Health and Disease. Cham: Springer International Publishing; 2018. pp. 279-93. [DOI: 10.1007/978-3-319-90545-7_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
169 Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009;50:185-197. [PMID: 19441102 DOI: 10.1002/hep.22952] [Cited by in Crossref: 273] [Cited by in F6Publishing: 264] [Article Influence: 21.0] [Reference Citation Analysis]
170 Zhou X, Han D, Xu R, Wu H, Qu C, Wang F, Wang X, Zhao Y. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. Oncotarget 2016;7:80223-37. [PMID: 27784003 DOI: 10.18632/oncotarget.12831] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
171 Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:691-701. [PMID: 21045794 DOI: 10.1038/nrgastro.2010.172] [Cited by in Crossref: 298] [Cited by in F6Publishing: 273] [Article Influence: 24.8] [Reference Citation Analysis]
172 Bibbò S, Ianiro G, Dore MP, Simonelli C, Newton EE, Cammarota G. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. Mediators Inflamm 2018;2018:9321643. [PMID: 29563854 DOI: 10.1155/2018/9321643] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
173 Alshaikh AE, Hassan HA. Gut-kidney axis in oxalate homeostasis. Curr Opin Nephrol Hypertens 2021;30:264-74. [PMID: 33427760 DOI: 10.1097/MNH.0000000000000690] [Reference Citation Analysis]
174 Coate KC, Kraft G, Lautz M, Smith M, Neal DW, Cherrington AD. A high-fat, high-fructose diet accelerates nutrient absorption and impairs net hepatic glucose uptake in response to a mixed meal in partially pancreatectomized dogs. J Nutr 2011;141:1643-51. [PMID: 21775526 DOI: 10.3945/jn.111.145359] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
175 Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C, Valet P, Girard M, Muccioli GG, François P, de Vos WM, Schrenzel J, Delzenne NM, Cani PD. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2011;2:149. [PMID: 21808634 DOI: 10.3389/fmicb.2011.00149] [Cited by in Crossref: 189] [Cited by in F6Publishing: 183] [Article Influence: 17.2] [Reference Citation Analysis]
176 Frasca D, Diaz A, Romero M, Vazquez T, Strbo N, Romero L, McCormack RM, Podack ER, Blomberg BB. Impaired B Cell Function in Mice Lacking Perforin-2. Front Immunol 2020;11:328. [PMID: 32180773 DOI: 10.3389/fimmu.2020.00328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
177 Trovato GM, Martines GF, Pirri C, Trovato FM, Castro A, Garozzo A, Catalano D. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012;46:e46-e54. [PMID: 22476041 DOI: 10.1097/mcg.0b013e31824b225c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
178 He C, Shan Y, Song W. Targeting gut microbiota as a possible therapy for diabetes. Nutr Res 2015;35:361-7. [PMID: 25818484 DOI: 10.1016/j.nutres.2015.03.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 10.0] [Reference Citation Analysis]
179 Knudsen C, Neyrinck AM, Leyrolle Q, Baldin P, Leclercq S, Rodriguez J, Beaumont M, Cani PD, Bindels LB, Lanthier N, Delzenne NM. Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. J Nutr 2021;151:1507-16. [PMID: 33693866 DOI: 10.1093/jn/nxab032] [Reference Citation Analysis]
180 Le Dréan G, Haure-Mirande V, Ferrier L, Bonnet C, Hulin P, de Coppet P, Segain JP. Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway. FASEB J 2014;28:1059-70. [PMID: 24243887 DOI: 10.1096/fj.13-234203] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
181 Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-5. [PMID: 18641190 DOI: 10.1093/jn/138.8.1452] [Cited by in Crossref: 289] [Cited by in F6Publishing: 270] [Article Influence: 20.6] [Reference Citation Analysis]
182 Wang X, Li MM, Niu Y, Zhang X, Yin JB, Zhao CJ, Wang RT. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma. Dis Markers 2019;2019:5945721. [PMID: 31485278 DOI: 10.1155/2019/5945721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
183 Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010;6:392. [PMID: 20664638 DOI: 10.1038/msb.2010.46] [Cited by in Crossref: 384] [Cited by in F6Publishing: 352] [Article Influence: 32.0] [Reference Citation Analysis]
184 Anselmi G, Gagliardi L, Egidi G, Leone S, Gasbarrini A, Miggiano GAD, Galiuto L. Gut Microbiota and Cardiovascular Diseases: A Critical Review. Cardiol Rev 2021;29:195-204. [PMID: 32639240 DOI: 10.1097/CRD.0000000000000327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
185 Ahola AJ, Lassenius MI, Forsblom C, Harjutsalo V, Lehto M, Groop PH. Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity. Sci Rep 2017;7:6511. [PMID: 28747701 DOI: 10.1038/s41598-017-06885-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
186 Oz HS, Chen TS, Neuman M. Nutrition intervention: a strategy against systemic inflammatory syndrome. JPEN J Parenter Enteral Nutr 2009;33:380-9. [PMID: 19380752 DOI: 10.1177/0148607108327194] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
187 Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect. 2012;18 Suppl 4:50-53. [PMID: 22647050 DOI: 10.1111/j.1469-0691.2012.03866.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
188 Skouroliakou M, Ntountaniotis D, Kastanidou O, Massara P. Evaluation of Barley's Beta-glucan Food Fortification through Investigation of Intestinal Permeability in Healthy Adults. Journal of the American College of Nutrition 2015;35:13-9. [DOI: 10.1080/07315724.2014.967893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
189 Lu X, Liu J, Zhang N, Fu Y, Zhang Z, Li Y, Wang W, Li Y, Shen P, Cao Y. Ripened Pu-erh Tea Extract Protects Mice from Obesity by Modulating Gut Microbiota Composition. J Agric Food Chem 2019;67:6978-94. [PMID: 31070363 DOI: 10.1021/acs.jafc.8b04909] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
190 Davison KM, Temple NJ. Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox. Journal of Diabetes and its Complications 2018;32:240-5. [DOI: 10.1016/j.jdiacomp.2017.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
191 Ponzetti K, King M, Gates A, Anwer MS, Webster CR. Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes. Hepat Med 2010;2010:1-11. [PMID: 21743791 DOI: 10.2147/HMER.S7673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
192 Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes 2015; 6(4): 598-612 [PMID: 25987957 DOI: 10.4239/wjd.v6.i4.598] [Cited by in CrossRef: 163] [Cited by in F6Publishing: 153] [Article Influence: 23.3] [Reference Citation Analysis]
193 Abu-tair L, Doron S, Mahamid M, Amer J, Safadi R. Leptin modulates lymphocytes' adherence to hepatic stellate cells is associated with oxidative status alterations. Mitochondrion 2013;13:473-80. [DOI: 10.1016/j.mito.2012.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
194 Wang Y, Dellatore P, Douard V, Qin L, Watford M, Ferraris RP, Lin T, Shapses SA. High fat diet enriched with saturated, but not monounsaturated fatty acids adversely affects femur, and both diets increase calcium absorption in older female mice. Nutr Res 2016;36:742-50. [PMID: 27262536 DOI: 10.1016/j.nutres.2016.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
195 Nitta T, Kanoh H, Inamori KI, Suzuki A, Takahashi T, Inokuchi JI. Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy. Glycobiology 2019;29:260-8. [PMID: 30476082 DOI: 10.1093/glycob/cwy105] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
196 Hamilton MK, Boudry G, Lemay DG, Raybould HE. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol 2015;308:G840-51. [PMID: 25747351 DOI: 10.1152/ajpgi.00029.2015] [Cited by in Crossref: 149] [Cited by in F6Publishing: 147] [Article Influence: 21.3] [Reference Citation Analysis]
197 Sun X, Du M, Navarre DA, Zhu MJ. Purple Potato Extract Promotes Intestinal Epithelial Differentiation and Barrier Function by Activating AMP-Activated Protein Kinase. Mol Nutr Food Res 2018;62. [PMID: 29193691 DOI: 10.1002/mnfr.201700536] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
198 Qiu X, Zhang F, Yang X, Wu N, Jiang W, Li X, Li X, Liu Y. Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci Rep 2015;5:10416. [PMID: 26013555 DOI: 10.1038/srep10416] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
199 Kim JH, Heo JS, Baek KS, Kim S, Kim JH, Baek K, Kim KE, Sheen YH. Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents. Clinica Chimica Acta 2018;481:218-24. [DOI: 10.1016/j.cca.2018.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
200 Metcalfe D, Harte A, Aletrari M, Al Daghri N, Al Disi D, Tripathi G, Mcternan P. Does endotoxaemia contribute to osteoarthritis in obese patients? Clinical Science 2012;123:627-34. [DOI: 10.1042/cs20120073] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
201 Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670-678. [PMID: 18666225 DOI: 10.1002/hep.22399] [Cited by in Crossref: 136] [Cited by in F6Publishing: 143] [Article Influence: 9.7] [Reference Citation Analysis]
202 Stuart MJ, Baune BT. Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neuroscience & Biobehavioral Reviews 2012;36:658-76. [DOI: 10.1016/j.neubiorev.2011.10.001] [Cited by in Crossref: 147] [Cited by in F6Publishing: 128] [Article Influence: 14.7] [Reference Citation Analysis]
203 Amir M, Czaja MJ. Autophagy in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol. 2011;5:159-166. [PMID: 21476911 DOI: 10.1586/egh.11.4] [Cited by in Crossref: 141] [Cited by in F6Publishing: 142] [Article Influence: 12.8] [Reference Citation Analysis]
204 Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med 2020;9:E2648. [PMID: 32823983 DOI: 10.3390/jcm9082648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
205 Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, Sánchez-Margalet V. Role of Leptin in Inflammation and Vice Versa. Int J Mol Sci 2020;21:E5887. [PMID: 32824322 DOI: 10.3390/ijms21165887] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
206 Hatton-Jones KM, du Toit EF, Cox AJ. Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice. Neurogastroenterol Motil 2021;:e14300. [PMID: 34825433 DOI: 10.1111/nmo.14300] [Reference Citation Analysis]
207 Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Kaji K, Aihara Y, Nishimura N, Takeda K. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Mol Med Rep. 2015;11:1693-1700. [PMID: 25421042 DOI: 10.3892/mmr.2014.2995] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
208 Ye C, Liu L, Ma X, Tong H, Gao J, Tai Y, Huang L, Tang C, Wang R. Obesity Aggravates Acute Pancreatitis via Damaging Intestinal Mucosal Barrier and Changing Microbiota Composition in Rats. Sci Rep. 2019;9:69. [PMID: 30635594 DOI: 10.1038/s41598-018-36266-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
209 Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013;8:e54600. [PMID: 23349936 DOI: 10.1371/journal.pone.0054600] [Cited by in Crossref: 114] [Cited by in F6Publishing: 111] [Article Influence: 12.7] [Reference Citation Analysis]
210 Zhou HJ, Kong LL, Zhu LX, Hu XY, Busye J, Song ZG. Effects of cold stress on growth performance, serum biochemistry, intestinal barrier molecules, and adenosine monophosphate-activated protein kinase in broilers. Animal 2021;15:100138. [PMID: 33573943 DOI: 10.1016/j.animal.2020.100138] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol. 2011;55:1391-1399. [PMID: 21703208 DOI: 10.1016/j.jhep.2011.02.035] [Cited by in Crossref: 149] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
212 Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surgery for Obesity and Related Diseases 2015;11:45-53. [DOI: 10.1016/j.soard.2014.05.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
213 Miyata Y, Fukuhara A, Otsuki M, Shimomura I. Expression of activating transcription factor 2 in inflammatory macrophages in obese adipose tissue. Obesity (Silver Spring) 2013;21:731-6. [PMID: 23712976 DOI: 10.1002/oby.20274] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
214 Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58:704-720. [PMID: 19359436 DOI: 10.1136/gut.2008.156307] [Cited by in Crossref: 225] [Cited by in F6Publishing: 226] [Article Influence: 17.3] [Reference Citation Analysis]
215 Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol 2016; 8(32): 1354-1369 [PMID: 27917262 DOI: 10.4254/wjh.v8.i32.1354] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
216 Al-Disi DA, Al-Daghri NM, Khan N, Alfadda AA, Sallam RM, Alsaif M, Sabico S, Tripathi G, McTernan PG. Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases. Nutrients 2015;7:6375-89. [PMID: 26247966 DOI: 10.3390/nu7085290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
217 Chen JJ, Wang R, Li XF, Wang RL. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med (Maywood). 2011;236:823-831. [PMID: 21685239 DOI: 10.1258/ebm.2011.010399] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
218 Bäckhed F. Addressing the gut microbiome and implications for obesity. International Dairy Journal 2010;20:259-61. [DOI: 10.1016/j.idairyj.2009.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
219 Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7:639-646. [PMID: 21826100 DOI: 10.1038/nrendo.2011.126] [Cited by in Crossref: 488] [Cited by in F6Publishing: 438] [Article Influence: 44.4] [Reference Citation Analysis]
220 Ruiz AG, Casafont F, Crespo J, Cayón A, Mayorga M, Estebanez A, Fernadez-Escalante JC, Pons-Romero F. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007;17:1374-1380. [PMID: 18000721 DOI: 10.1007/s11695-007-9243-7] [Cited by in Crossref: 186] [Cited by in F6Publishing: 180] [Article Influence: 13.3] [Reference Citation Analysis]
221 Etxeberria U, Arias N, Boqué N, Macarulla MT, Portillo MP, Martínez JA, Milagro FI. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem 2015;26:651-60. [PMID: 25762527 DOI: 10.1016/j.jnutbio.2015.01.002] [Cited by in Crossref: 223] [Cited by in F6Publishing: 220] [Article Influence: 31.9] [Reference Citation Analysis]
222 Villarroya F, Cereijo R, Gavaldà-Navarro A, Villarroya J, Giralt M. Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J Intern Med 2018;284:492-504. [PMID: 29923291 DOI: 10.1111/joim.12803] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 18.3] [Reference Citation Analysis]
223 Lam YY, Ha CW, Hoffmann JM, Oscarsson J, Dinudom A, Mather TJ, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH. Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice: Effect of Dietary Fat on Gut Health. Obesity 2015;23:1429-39. [DOI: 10.1002/oby.21122] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 13.6] [Reference Citation Analysis]
224 Utzschneider KM, Kratz M, Damman CJ, Hullar M. Mechanisms Linking the Gut Microbiome and Glucose Metabolism. J Clin Endocrinol Metab 2016;101:1445-54. [PMID: 26938201 DOI: 10.1210/jc.2015-4251] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 13.8] [Reference Citation Analysis]
225 Westwell-Roper C, Nackiewicz D, Dan M, Ehses JA. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes. Immunol Cell Biol 2014;92:314-23. [PMID: 24492799 DOI: 10.1038/icb.2014.4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.8] [Reference Citation Analysis]
226 Singh H, Miyamoto S, Darshi M, Torralba MG, Kwon K, Sharma K, Pieper R. Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment. Microorganisms 2020;8:E1347. [PMID: 32899353 DOI: 10.3390/microorganisms8091347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Mujawdiya PK, Sharma P, Sharad S, Kapur S. Reversal of Increase in Intestinal Permeability by Mangifera indica Seed Kernel Extract in High-Fat Diet-Induced Obese Mice. Pharmaceuticals (Basel) 2020;13:E190. [PMID: 32796561 DOI: 10.3390/ph13080190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Fukunishi S, Sujishi T, Takeshita A, Ohama H, Tsuchimoto Y, Asai A, Tsuda Y, Higuchi K. Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats. J Clin Biochem Nutr 2014;54:39-44. [PMID: 24426189 DOI: 10.3164/jcbn.13-49] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
229 Pace F, Carvalho BM, Zanotto TM, Santos A, Guadagnini D, Silva KLC, Mendes MCS, Rocha GZ, Alegretti SM, Santos GA, Catharino RR, Paroni R, Folli F, Saad MJA. Helminth infection in mice improves insulin sensitivity via modulation of gut microbiota and fatty acid metabolism. Pharmacol Res 2018;132:33-46. [PMID: 29653264 DOI: 10.1016/j.phrs.2018.04.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
230 Chakaroun RM, Massier L, Kovacs P. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? Nutrients 2020;12:E1082. [PMID: 32295104 DOI: 10.3390/nu12041082] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
231 Vojdani A, Lambert J. The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II. Evid Based Complement Alternat Med 2011;2011:984965. [PMID: 19622601 DOI: 10.1093/ecam/nep063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
232 Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009;50:185-197. [PMID: 19441102 DOI: 10.1002/hep.22952.ccr2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Cheung KP, Taylor KR, Jameson JM. Immunomodulation at epithelial sites by obesity and metabolic disease. Immunol Res 2012;52:182-99. [PMID: 22160809 DOI: 10.1007/s12026-011-8261-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
234 Kelly CJ, Colgan SP, Frank DN. Of microbes and meals: the health consequences of dietary endotoxemia. Nutr Clin Pract 2012;27:215-25. [PMID: 22378797 DOI: 10.1177/0884533611434934] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
235 Yook J, Kim K, Kim M, Cha Y. Black Adzuki Bean ( Vigna angularis ) Attenuates High-Fat Diet-Induced Colon Inflammation in Mice. Journal of Medicinal Food 2017;20:367-75. [DOI: 10.1089/jmf.2016.3821] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
236 Nie P, Li Z, Wang Y, Zhang Y, Zhao M, Luo J, Du S, Deng Z, Chen J, Wang Y, Chen S, Wang L. Gut microbiome interventions in human health and diseases. Med Res Rev 2019;39:2286-313. [PMID: 30994937 DOI: 10.1002/med.21584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
237 Dibaise JK, Frank DN, Mathur R. Impact of the Gut Microbiota on the Development of Obesity: Current Concepts. Am J Gastroenterol Suppl 2012;1:22-7. [DOI: 10.1038/ajgsup.2012.5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 39] [Article Influence: 8.9] [Reference Citation Analysis]
238 Pimentel GD, Micheletti TO, Pace F, Rosa JC, Santos RV, Lira FS. Gut-central nervous system axis is a target for nutritional therapies. Nutr J 2012;11:22. [PMID: 22490672 DOI: 10.1186/1475-2891-11-22] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
239 Norris GH, Milard M, Michalski M, Blesso CN. Protective properties of milk sphingomyelin against dysfunctional lipid metabolism, gut dysbiosis, and inflammation. The Journal of Nutritional Biochemistry 2019;73:108224. [DOI: 10.1016/j.jnutbio.2019.108224] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
240 Gil-Cardoso K, Ginés I, Pinent M, Ardévol A, Blay M, Terra X. Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutr Res Rev 2016;29:234-48. [PMID: 27841104 DOI: 10.1017/S0954422416000159] [Cited by in Crossref: 92] [Cited by in F6Publishing: 51] [Article Influence: 15.3] [Reference Citation Analysis]
241 Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012;7:e34233. [PMID: 22457829 DOI: 10.1371/journal.pone.0034233] [Cited by in Crossref: 310] [Cited by in F6Publishing: 305] [Article Influence: 31.0] [Reference Citation Analysis]
242 Dong X, Feng X, Liu J, Xu Y, Pan Q, Ling Z, Yu J, Yang J, Li L, Cao H. Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury. Stem Cells Int 2019;2019:2403793. [PMID: 30867666 DOI: 10.1155/2019/2403793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
243 Baldassano S, Amato A, Rappa F, Cappello F, Mulè F. Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet. Endocrine Research 2016;41:317-24. [DOI: 10.3109/07435800.2016.1141950] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
244 Sharifnia T, Antoun J, Verriere TG, Suarez G, Wattacheril J, Wilson KT, Peek RM, Abumrad NN, Flynn CR. Hepatic TLR4 signaling in obese NAFLD. Am J Physiol Gastrointest Liver Physiol. 2015;309:G270-G278. [PMID: 26113297 DOI: 10.1152/ajpgi.00304.2014] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 15.7] [Reference Citation Analysis]
245 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 247] [Cited by in F6Publishing: 231] [Article Influence: 24.7] [Reference Citation Analysis]
246 Ilchmann-Diounou H, Olier M, Lencina C, Riba A, Barretto S, Nankap M, Sommer C, Guillou H, Ellero-Simatos S, Guzylack-Piriou L, Théodorou V, Ménard S. Early life stress induces type 2 diabetes-like features in ageing mice. Brain Behav Immun 2019;80:452-63. [PMID: 30981713 DOI: 10.1016/j.bbi.2019.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
247 Massey VL, Stocke KS, Schmidt RH, Tan M, Ajami N, Neal RE, Petrosino JF, Barve S, Arteel GE. Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction. Toxicol Appl Pharmacol 2015;284:304-14. [PMID: 25759243 DOI: 10.1016/j.taap.2015.02.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
248 Pan Y, Kong LD. High fructose diet-induced metabolic syndrome: Pathophysiological mechanism and treatment by traditional Chinese medicine. Pharmacol Res 2018;130:438-50. [PMID: 29471102 DOI: 10.1016/j.phrs.2018.02.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
249 Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. [PMID: 32158768 DOI: 10.3389/fcvm.2020.00022] [Cited by in Crossref: 107] [Cited by in F6Publishing: 114] [Article Influence: 53.5] [Reference Citation Analysis]
250 Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013;59:155-201. [PMID: 23461136 DOI: 10.1016/b978-0-12-405211-6.00006-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
251 Chen YH, Wang YC, Chiu CC, Lee YP, Hung SW, Huang CC, Chiu CF, Chen TH, Huang WC, Chuang HL. Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. J Nutr Biochem 2020;79:108362. [PMID: 32163832 DOI: 10.1016/j.jnutbio.2020.108362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
252 Kheder RK, Hobkirk J, Stover CM. In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity? Front Cell Dev Biol 2016;4:61. [PMID: 27446914 DOI: 10.3389/fcell.2016.00061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
253 Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol. 2013;13:935-940. [PMID: 24075718 DOI: 10.1016/j.coph.2013.09.008] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 23.3] [Reference Citation Analysis]
254 Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM, Rensen SS. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity: Obese Gut Microbiota and Inflammation. Obesity 2013;21:E607-15. [DOI: 10.1002/oby.20466] [Cited by in Crossref: 288] [Cited by in F6Publishing: 262] [Article Influence: 32.0] [Reference Citation Analysis]
255 Grippo RM, Tang Q, Zhang Q, Chadwick SR, Gao Y, Altherr EB, Sipe L, Purohit AM, Purohit NM, Sunkara MD, Cios KJ, Sidikpramana M, Spano AJ, Campbell JN, Steele AD, Hirsh J, Deppmann CD, Wu M, Scott MM, Güler AD. Dopamine Signaling in the Suprachiasmatic Nucleus Enables Weight Gain Associated with Hedonic Feeding. Curr Biol 2020;30:196-208.e8. [PMID: 31902720 DOI: 10.1016/j.cub.2019.11.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
256 Delaune V, Orci LA, Lacotte S, Peloso A, Schrenzel J, Lazarevic V, Toso C. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. Expert Opin Biol Ther 2018;18:1061-71. [PMID: 30173562 DOI: 10.1080/14712598.2018.1518424] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
257 Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 2021;20:65. [PMID: 34233682 DOI: 10.1186/s12944-021-01491-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Armstrong LE, Lee EC, Armstrong EM. Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke. J Sports Med (Hindawi Publ Corp) 2018;2018:5724575. [PMID: 29850597 DOI: 10.1155/2018/5724575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
259 Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 2009;50:1094-1104. [PMID: 19637282 DOI: 10.1002/hep.23122] [Cited by in Crossref: 352] [Cited by in F6Publishing: 351] [Article Influence: 27.1] [Reference Citation Analysis]
260 Kang Y, Kang X, Yang H, Liu H, Yang X, Liu Q, Tian H, Xue Y, Ren P, Kuang X, Cai Y, Tong M, Li L, Fan W. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol Res 2021;175:106020. [PMID: 34896249 DOI: 10.1016/j.phrs.2021.106020] [Reference Citation Analysis]
261 Johnson AM, Costanzo A, Gareau MG, Armando AM, Quehenberger O, Jameson JM, Olefsky JM. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One 2015;10:e0122195. [PMID: 25837594 DOI: 10.1371/journal.pone.0122195] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
262 Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010;69:211-20. [DOI: 10.1017/s0029665110000030] [Cited by in Crossref: 141] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
263 Geurts L, Everard A, le Ruyet P, Delzenne NM, Cani PD. Ripened dairy products differentially affect hepatic lipid content and adipose tissue oxidative stress markers in obese and type 2 diabetic mice. J Agric Food Chem 2012;60:2063-8. [PMID: 22300436 DOI: 10.1021/jf204916x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
264 Bigorgne AE, Bouchet-Delbos L, Naveau S, Dagher I, Prévot S, Durand-Gasselin I, Couderc J, Valet P, Emilie D, Perlemuter G. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology 2008;134:1459-69. [PMID: 18471520 DOI: 10.1053/j.gastro.2008.02.055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
265 Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2014;15:7352-7379. [PMID: 24786095 DOI: 10.3390/ijms15057352] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
266 Norris GH, Blesso CN. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. Nutr Rev 2017;75:274-85. [PMID: 28383715 DOI: 10.1093/nutrit/nux004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
267 Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferriéres J. Energy intake is associated with endotoxemia in apparently healthy men. The American Journal of Clinical Nutrition 2008;87:1219-23. [DOI: 10.1093/ajcn/87.5.1219] [Cited by in Crossref: 385] [Cited by in F6Publishing: 343] [Article Influence: 27.5] [Reference Citation Analysis]
268 De Bandt JP, Monin C. Obesity, Nutrients and the Immune System in the Era of COVID-19. Nutrients 2021;13:610. [PMID: 33668493 DOI: 10.3390/nu13020610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
269 Guimarães VM, Santos VN, Borges PSDA, De Farias JLR, Grillo P, Parise ER. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS. Arq Gastroenterol 2020;57:471-6. [DOI: 10.1590/s0004-2803.202000000-82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
270 Mohammed N, Tang L, Jahangiri A, de Villiers W, Eckhardt E. Elevated IgG levels against specific bacterial antigens in obese patients with diabetes and in mice with diet-induced obesity and glucose intolerance. Metabolism 2012;61:1211-4. [PMID: 22424821 DOI: 10.1016/j.metabol.2012.02.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
271 Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012;7:e47713. [PMID: 23091640 DOI: 10.1371/journal.pone.0047713] [Cited by in Crossref: 559] [Cited by in F6Publishing: 560] [Article Influence: 55.9] [Reference Citation Analysis]
272 Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27:73-83. [PMID: 23768554 DOI: 10.1016/j.bpg.2013.03.007] [Cited by in Crossref: 323] [Cited by in F6Publishing: 284] [Article Influence: 35.9] [Reference Citation Analysis]
273 Cornide-Petronio ME, Álvarez-Mercado AI, Jiménez-Castro MB, Peralta C. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. Nutrients 2020;12:E284. [PMID: 31973190 DOI: 10.3390/nu12020284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
274 Guillemot L, Schneider Y, Brun P, Castagliuolo I, Pizzuti D, Martines D, Jond L, Bongiovanni M, Citi S. Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury. J Cell Sci 2012;125:5005-14. [PMID: 22946046 DOI: 10.1242/jcs.101261] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
275 Sun X, Zhu MJ. AMP-activated protein kinase: a therapeutic target in intestinal diseases. Open Biol 2017;7:170104. [PMID: 28835570 DOI: 10.1098/rsob.170104] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
276 Patterson E, Ryan PM, Cryan JF, Dinan TG, Ross RP, Fitzgerald GF, Stanton C. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92:286-300. [PMID: 26912499 DOI: 10.1136/postgradmedj-2015-133285] [Cited by in Crossref: 148] [Cited by in F6Publishing: 139] [Article Influence: 24.7] [Reference Citation Analysis]
277 Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther. 2010;32:1307-1314. [PMID: 21050232 DOI: 10.1111/j.1365-2036.2010.04475.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
278 Al-Sadi R, Ye D, Said HM, Ma TY. Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier. J Cell Mol Med 2011;15:970-82. [PMID: 20406328 DOI: 10.1111/j.1582-4934.2010.01065.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
279 Garcia-Martinez I, Shaker ME, Mehal WZ. Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases. Antioxid Redox Signal 2015;23:1305-15. [PMID: 26055926 DOI: 10.1089/ars.2015.6383] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
280 Accarie A, Vanuytsel T. Animal Models for Functional Gastrointestinal Disorders. Front Psychiatry 2020;11:509681. [PMID: 33262709 DOI: 10.3389/fpsyt.2020.509681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
281 Stenman LK, Holma R, Gylling H, Korpela R. Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr 2013;110:1157-64. [PMID: 23442231 DOI: 10.1017/S000711451300024X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
282 De Bandt J, Waligora-dupriet A, Butel M. Intestinal microbiota in inflammation and insulin resistance: relevance to humans: . Current Opinion in Clinical Nutrition and Metabolic Care 2011;14:334-40. [DOI: 10.1097/mco.0b013e328347924a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
283 Weidinger C, Hegazy AN, Siegmund B. The role of adipose tissue in inflammatory bowel diseases. Curr Opin Gastroenterol 2018;34:183-6. [PMID: 29846262 DOI: 10.1097/MOG.0000000000000445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
284 Cunningham AL, Stephens JW, Harris DA. Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity. J Diabetes Metab Disord 2021;20:1855-70. [PMID: 34900829 DOI: 10.1007/s40200-021-00858-4] [Reference Citation Analysis]
285 Alti D, Sambamurthy C, Kalangi SK. Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation. Front Cell Infect Microbiol 2018;8:147. [PMID: 29868503 DOI: 10.3389/fcimb.2018.00147] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
286 Jennis M, Cavanaugh CR, Leo GC, Mabus JR, Lenhard J, Hornby PJ. Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterol Motil. 2018;30. [PMID: 28782205 DOI: 10.1111/nmo.13178] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
287 Meroni M, Longo M, Dongiovanni P. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients. 2019;11. [PMID: 31689910 DOI: 10.3390/nu11112642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
288 Kieffer DA, Martin RJ, Adams SH. Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys. Adv Nutr 2016;7:1111-21. [PMID: 28140328 DOI: 10.3945/an.116.013219] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
289 Luo L, Zhou Z, Xue J, Wang Y, Zhang J, Cai X, Liu Y, Yang F. Bletilla striata polysaccharide has a protective effect on intestinal epithelial barrier disruption in TAA-induced cirrhotic rats. Exp Ther Med 2018;16:1715-22. [PMID: 30186392 DOI: 10.3892/etm.2018.6430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
290 Akai H, Kiryu S, Ohta Y, Yasaka K, Nakano Y, Inoue Y, Ohtomo K. The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice. Magn Reson Imaging 2017;38:123-8. [PMID: 28062263 DOI: 10.1016/j.mri.2016.12.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
291 Park C, Cheung KP, Limon N, Costanzo A, Barba C, Miranda N, Gargas S, Johnson AMF, Olefsky JM, Jameson JM. Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium–Induced Colitis. J I 2019;203:3427-35. [DOI: 10.4049/jimmunol.1900082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
292 Maguire M, Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev Neurosci. 2019;30:179-201. [PMID: 30173208 DOI: 10.1515/revneuro-2018-0024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
293 Li L, Rao S, Cheng Y, Zhuo X, Deng C, Xu N, Zhang H, Yang L. Microbial osteoporosis: The interplay between the gut microbiota and bones via host metabolism and immunity. Microbiologyopen 2019;8:e00810. [PMID: 31001921 DOI: 10.1002/mbo3.810] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
294 Wu CC, Weng WL, Lai WL, Tsai HP, Liu WH, Lee MH, Tsai YC. Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice. Evid Based Complement Alternat Med 2015;2015:391767. [PMID: 25802537 DOI: 10.1155/2015/391767] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
295 Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci 2014;15:8591-638. [PMID: 24830559 DOI: 10.3390/ijms15058591] [Cited by in Crossref: 178] [Cited by in F6Publishing: 164] [Article Influence: 22.3] [Reference Citation Analysis]
296 Xue L, He J, Gao N, Lu X, Li M, Wu X, Liu Z, Jin Y, Liu J, Xu J, Geng Y. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep. 2017;7:45176. [PMID: 28349964 DOI: 10.1038/srep45176] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 19.2] [Reference Citation Analysis]
297 Teixeira TF, Souza NC, Chiarello PG, Franceschini SC, Bressan J, Ferreira CL, Peluzio MDCG. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clinical Nutrition 2012;31:735-40. [DOI: 10.1016/j.clnu.2012.02.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 10.6] [Reference Citation Analysis]
298 Knorr J, Wree A, Tacke F, Feldstein AE. The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. Semin Liver Dis 2020;40:298-306. [PMID: 32526788 DOI: 10.1055/s-0040-1708540] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
299 Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond). 2010;7:19. [PMID: 20222989 DOI: 10.1186/1743-7075-7-19] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 9.0] [Reference Citation Analysis]
300 Delzenne NM, Cani PD. [Gut microflora is a key player in host energy homeostasis]. Med Sci (Paris) 2008;24:505-10. [PMID: 18466728 DOI: 10.1051/medsci/2008245505] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
301 Yoon HJ, Cha BS. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 2014; 6(11): 800-811 [PMID: 25429318 DOI: 10.4254/wjh.v6.i11.800] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
302 Kishida Y, Okubo H, Ohno H, Oki K, Yoneda M. Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model. J Gastroenterol. 2017;52:1180-1191. [PMID: 28349245 DOI: 10.1007/s00535-017-1331-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
303 Pinzani M, Macias-Barragan J. Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol 2010;4:459-72. [PMID: 20678019 DOI: 10.1586/egh.10.47] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
304 Huazano-García A, Silva-Adame MB, Vázquez-Martínez J, Gastelum-Arellanez A, Sánchez-Segura L, López MG. Highly Branched Neo-Fructans (Agavins) Attenuate Metabolic Endotoxemia and Low-Grade Inflammation in Association with Gut Microbiota Modulation on High-Fat Diet-Fed Mice. Foods 2020;9:E1792. [PMID: 33287102 DOI: 10.3390/foods9121792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
305 He K, Ma H, Xu H, Zou Z, Feng M, Li X, Ye X. Anti-hyperlipidemic effects of Rhizoma Coptidis alkaloids are achieved through modulation of the enterohepatic circulation of bile acids and cross-talk between the gut microbiota and the liver. Journal of Functional Foods 2017;35:205-15. [DOI: 10.1016/j.jff.2017.04.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
306 Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier function and metabolic/liver diseases. Liver Research 2020;4:81-7. [DOI: 10.1016/j.livres.2020.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
307 Leclercq S, Mian FM, Stanisz AM, Bindels LB, Cambier E, Ben-Amram H, Koren O, Forsythe P, Bienenstock J. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat Commun 2017;8:15062. [PMID: 28375200 DOI: 10.1038/ncomms15062] [Cited by in Crossref: 185] [Cited by in F6Publishing: 165] [Article Influence: 37.0] [Reference Citation Analysis]
308 Pimentel-Nunes P, Soares JB, Roncon-Albuquerque R, Dinis-Ribeiro M, Leite-Moreira AF. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets. 2010;14:347-368. [PMID: 20146632 DOI: 10.1517/14728221003642027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
309 Wang C, Zhu C, Shao L, Ye J, Shen Y, Ren Y. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. Mediators Inflamm. 2019;2019:7659509. [PMID: 31341422 DOI: 10.1155/2019/7659509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
310 Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19(40): 6911-6918 [PMID: 24187469 DOI: 10.3748/wjg.v19.i40.6911] [Cited by in CrossRef: 195] [Cited by in F6Publishing: 174] [Article Influence: 21.7] [Reference Citation Analysis]
311 Qian LL, Li HT, Zhang L, Fang QC, Jia WP. Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update. Biomedical and Environmental Sciences 2015;28:839-47. [DOI: 10.1016/s0895-3988(15)30116-1] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
312 Lalande C, Drouin-Chartier JP, Tremblay AJ, Couture P, Veilleux A. Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterations. Diabetol Metab Syndr 2020;12:31. [PMID: 32292494 DOI: 10.1186/s13098-020-00530-6] [Reference Citation Analysis]
313 Richards JL, Yap YA, McLeod KH, Mackay CR, Mariño E. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology 2016;5:e82. [PMID: 27350881 DOI: 10.1038/cti.2016.29] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 17.3] [Reference Citation Analysis]
314 Bashir M, Meddings J, Alshaikh A, Jung D, Le K, Amin R, Ratakonda S, Sharma S, Granja I, Satti M, Asplin J, Hassan H. Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria. Am J Physiol Gastrointest Liver Physiol 2019;316:G1-G14. [PMID: 30307745 DOI: 10.1152/ajpgi.00266.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
315 Bischoff SC. 'Gut health': a new objective in medicine? BMC Med. 2011;9:24. [PMID: 21401922 DOI: 10.1186/1741-7015-9-24] [Cited by in Crossref: 149] [Cited by in F6Publishing: 127] [Article Influence: 13.5] [Reference Citation Analysis]
316 Harakeh SM, Khan I, Kumosani T, Barbour E, Almasaudi SB, Bahijri SM, Alfadul SM, Ajabnoor GM, Azhar EI. Gut Microbiota: A Contributing Factor to Obesity. Front Cell Infect Microbiol 2016;6:95. [PMID: 27625997 DOI: 10.3389/fcimb.2016.00095] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
317 Fukada H, Yamashina S, Izumi K, Komatsu M, Tanaka K, Ikejima K, Watanabe S. Suppression of autophagy sensitizes Kupffer cells to endotoxin: Autophagy and Kupffer cell sensitivity. Hepatology Research 2012;42:1112-8. [DOI: 10.1111/j.1872-034x.2012.01024.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
318 Haub S, Ritze Y, Ladel I, Saum K, Hubert A, Spruss A, Trautwein C, Bischoff SC. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. J Pharmacol Exp Ther. 2011;339:790-798. [PMID: 21903748 DOI: 10.1124/jpet.111.181834] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
319 Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract 2012;27:201-14. [PMID: 22367888 DOI: 10.1177/0884533611436116] [Cited by in Crossref: 295] [Cited by in F6Publishing: 253] [Article Influence: 29.5] [Reference Citation Analysis]
320 Lu S, Zhang T, Gu W, Yang X, Lu J, Zhao R, Yu J. Volatile Oil of Amomum villosum Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis. Biomed Res Int 2018;2018:3589874. [PMID: 30112382 DOI: 10.1155/2018/3589874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
321 Lloret-linares C, Miyauchi E, Luo H, Labat L, Bouillot J, Poitou C, Oppert J, Laplanche J, Mouly S, Scherrmann J, Uchida Y, Tachikawa M, Terasaki T, Bergmann J, Declèves X. Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers. Mol Pharmaceutics 2016;13:766-73. [DOI: 10.1021/acs.molpharmaceut.5b00656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
322 Micó-Carnero M, Rojano-Alfonso C, Álvarez-Mercado AI, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. Int J Mol Sci 2020;22:E44. [PMID: 33375200 DOI: 10.3390/ijms22010044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
323 Martínez-Álvaro M, Zubiri-Gaitán A, Hernández P, Greenacre M, Ferrer A, Blasco A. Comprehensive functional core microbiome comparison in genetically obese and lean hosts under the same environment. Commun Biol 2021;4:1246. [PMID: 34725460 DOI: 10.1038/s42003-021-02784-w] [Reference Citation Analysis]
324 Delzenne NM, Cani PD. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics. International Dairy Journal 2010;20:277-80. [DOI: 10.1016/j.idairyj.2009.11.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
325 Macedo MH, Martínez E, Barrias CC, Sarmento B. Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds. Front Bioeng Biotechnol 2020;8:524018. [PMID: 33042961 DOI: 10.3389/fbioe.2020.524018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
326 Madan R, Petri WA Jr. Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection. Anaerobe 2015;34:182-6. [PMID: 25638400 DOI: 10.1016/j.anaerobe.2014.12.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
327 Yahya RS, Awad SI, Kizilbash N, El-Baz HA, Atia G. Enteric parasites can disturb leptin and adiponectin levels in children. Arch Med Sci 2018;14:101-6. [PMID: 29379539 DOI: 10.5114/aoms.2016.60707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
328 Uusitupa HM, Rasinkangas P, Lehtinen MJ, Mäkelä SM, Airaksinen K, Anglenius H, Ouwehand AC, Maukonen J. Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research. Nutrients 2020;12:E892. [PMID: 32218248 DOI: 10.3390/nu12040892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
329 Liu TW, Cephas KD, Holscher HD, Kerr KR, Mangian HF, Tappenden KA, Swanson KS. Nondigestible Fructans Alter Gastrointestinal Barrier Function, Gene Expression, Histomorphology, and the Microbiota Profiles of Diet-Induced Obese C57BL/6J Mice. J Nutr 2016;146:949-56. [PMID: 27052535 DOI: 10.3945/jn.115.227504] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
330 Heyman-Lindén L, Kotowska D, Sand E, Bjursell M, Plaza M, Turner C, Holm C, Fåk F, Berger K. Lingonberries alter the gut microbiota and prevent low-grade inflammation in high-fat diet fed mice. Food Nutr Res 2016;60:29993. [PMID: 27125264 DOI: 10.3402/fnr.v60.29993] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
331 Bishehsari F, Engen PA, Adnan D, Sarrafi S, Wilber S, Shaikh M, Green SJ, Naqib A, Giron LB, Abdel-Mohsen M, Keshavarzian A. Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota. Transl Res 2021;231:113-23. [PMID: 33221482 DOI: 10.1016/j.trsl.2020.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Ip BC, Wang XD. Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. Nutrients. 2014;6:124-162. [PMID: 24379011 DOI: 10.3390/nu6010124] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
333 Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327-336. [PMID: 21677749 DOI: 10.1038/nature10213] [Cited by in Crossref: 1505] [Cited by in F6Publishing: 1312] [Article Influence: 136.8] [Reference Citation Analysis]
334 Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012;142:1100-1101.e2. [PMID: 22326433 DOI: 10.1053/j.gastro.2012.01.034] [Cited by in Crossref: 259] [Cited by in F6Publishing: 250] [Article Influence: 25.9] [Reference Citation Analysis]
335 Barlow GM, Yu A, Mathur R. Role of the Gut Microbiome in Obesity and Diabetes Mellitus. Nutr Clin Pract 2015;30:787-97. [PMID: 26452391 DOI: 10.1177/0884533615609896] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 15.0] [Reference Citation Analysis]
336 van Best N, Jansen PL, Rensen SS. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. Hepatol Int. 2015;9:406-415. [PMID: 26067771 DOI: 10.1007/s12072-015-9640-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
337 Spruss A, Bergheim I. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem. 2009;20:657-662. [PMID: 19679262 DOI: 10.1016/j.jnutbio.2009.05.006] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 8.4] [Reference Citation Analysis]
338 Cengiz M, Ozenirler S, Elbeg S. Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis. J Gastroenterol Hepatol. 2015;30:1190-1196. [PMID: 25684563 DOI: 10.1111/jgh.12924] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
339 Chung MY, Yeung SF, Park HJ, Volek JS, Bruno RS. Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. J Nutr Biochem. 2010;21:1200-1206. [PMID: 20138495 DOI: 10.1016/j.jnutbio.2009.10.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
340 Pinzone MR, Celesia BM, Di Rosa M, Cacopardo B, Nunnari G. Microbial translocation in chronic liver diseases. Int J Microbiol 2012;2012:694629. [PMID: 22848224 DOI: 10.1155/2012/694629] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
341 Caesar R, Fåk F, Bäckhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism: Review: Gut microbiota and metabolism. Journal of Internal Medicine 2010;268:320-8. [DOI: 10.1111/j.1365-2796.2010.02270.x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 161] [Article Influence: 14.8] [Reference Citation Analysis]
342 Suzuki T, Imai J, Yamada T, Ishigaki Y, Kaneko K, Uno K, Hasegawa Y, Ishihara H, Oka Y, Katagiri H. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 2011;60:537-47. [PMID: 21270264 DOI: 10.2337/db10-0796] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
343 Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, Ferreira AV, de Faria AM, Cara DC, Alvarez Leite JI. The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis. 2011;10:204. [PMID: 22073943 DOI: 10.1186/1476-511x-10-204] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
344 Wang X, Zhang ZF, Zheng GH, Wang AM, Sun CH, Qin SP, Zhuang J, Lu J, Ma DF, Zheng YL. The Inhibitory Effects of Purple Sweet Potato Color on Hepatic Inflammation Is Associated with Restoration of NAD⁺ Levels and Attenuation of NLRP3 Inflammasome Activation in High-Fat-Diet-Treated Mice. Molecules 2017;22:E1315. [PMID: 28786950 DOI: 10.3390/molecules22081315] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
345 Ogura K, Ogura M, Shoji T, Sato Y, Tahara Y, Yamano G, Sato H, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N, Nagashima K. Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice. J Agric Food Chem 2016;64:8857-65. [DOI: 10.1021/acs.jafc.6b03424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
346 Le Gall M, Thenet S, Aguanno D, Jarry AC, Genser L, Ribeiro-Parenti L, Joly F, Ledoux S, Bado A, Le Beyec J. Intestinal plasticity in response to nutrition and gastrointestinal surgery. Nutr Rev 2019;77:129-43. [PMID: 30517714 DOI: 10.1093/nutrit/nuy064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
347 Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int. 2011;31:1432-1448. [PMID: 22093324 DOI: 10.1111/j.1478-3231.2011.02604.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 109] [Article Influence: 11.7] [Reference Citation Analysis]
348 Ott B, Skurk T, Lagkouvardos L, Fischer S, Büttner J, Lichtenegger M, Clavel T, Lechner A, Rychlik M, Haller D, Hauner H. Short-Term Overfeeding with Dairy Cream Does Not Modify Gut Permeability, the Fecal Microbiota, or Glucose Metabolism in Young Healthy Men. J Nutr 2018;148:77-85. [PMID: 29378051 DOI: 10.1093/jn/nxx020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
349 Liddle DM, Hutchinson AL, Wellings HR, Power KA, Robinson LE, Monk JM. Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction. Nutrients 2017;9:E1289. [PMID: 29186929 DOI: 10.3390/nu9121289] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
350 Chen J, Wang R, Li XF, Wang RL. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr. 2012;107:1429-1434. [PMID: 21914236 DOI: 10.1017/s0007114511004491] [Cited by in Crossref: 78] [Cited by in F6Publishing: 39] [Article Influence: 7.1] [Reference Citation Analysis]
351 Fukui H. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms. 2015;3:759-791. [PMID: 27682116 DOI: 10.3390/microorganisms3040759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
352 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
353 Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J Mol Endocrinol 2013;51:R51-64. [PMID: 23943858 DOI: 10.1530/JME-13-0079] [Cited by in Crossref: 111] [Cited by in F6Publishing: 57] [Article Influence: 12.3] [Reference Citation Analysis]
354 Chalubinski M, Wojdan K, Luczak E, Gorzelak-Pabis P, Kluszczynska K, Borowiec M, Gajewski A, Rudnicka K, Chmiela M, Broncel M. Escherichia coli lipopolysaccharide may affect the endothelial barrier and IL-10 expression of apolipoprotein B100-pulsed dendritic cells. APMIS 2020;128:10-9. [PMID: 31642122 DOI: 10.1111/apm.12999] [Reference Citation Analysis]
355 Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13:3-15. [PMID: 30791839 DOI: 10.1080/17474124.2019.1543023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
356 Al-Sadi R, Boivin M, Ma T. Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci (Landmark Ed). 2009;14:2765-2778. [PMID: 19273235 DOI: 10.2741/3413] [Cited by in Crossref: 271] [Cited by in F6Publishing: 272] [Article Influence: 20.8] [Reference Citation Analysis]
357 Kuang YS, Lu JH, Li SH, Li JH, Yuan MY, He JR, Chen NN, Xiao WQ, Shen SY, Qiu L, Wu YF, Hu CY, Wu YY, Li WD, Chen QZ, Deng HW, Papasian CJ, Xia HM, Qiu X. Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience 2017;6:1-12. [PMID: 28873967 DOI: 10.1093/gigascience/gix058] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 20.5] [Reference Citation Analysis]
358 Arroba AI, Valverde ÁM. Modulation of microglia in the retina: new insights into diabetic retinopathy. Acta Diabetol 2017;54:527-33. [PMID: 28349217 DOI: 10.1007/s00592-017-0984-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
359 Kim H, Bartley GE, Young SA, Davis PA, Yokoyama W. HPMC supplementation reduces abdominal fat content, intestinal permeability, inflammation, and insulin resistance in diet-induced obese mice. Mol Nutr Food Res 2012;56:1464-76. [DOI: 10.1002/mnfr.201200082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
360 Tal M, Weese JS, Gomez DE, Hesta M, Steiner JM, Verbrugghe A. Bacterial fecal microbiota is only minimally affected by a standardized weight loss plan in obese cats. BMC Vet Res 2020;16:112. [PMID: 32293441 DOI: 10.1186/s12917-020-02318-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
361 Zhou X, Han D, Yang X, Wang X, Qiao A. Glucose regulated protein 78 is potentially an important player in the development of nonalcoholic steatohepatitis. Gene 2017;637:138-44. [DOI: 10.1016/j.gene.2017.09.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
362 Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal. 2011;14:2121-2135. [PMID: 21083420 DOI: 10.1089/ars.2010.3263] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
363 Dvoriantchikova G, Santos AR, Saeed AM, Dvoriantchikova X, Ivanov D. Putative role of protein kinase C in neurotoxic inflammation mediated by extracellular heat shock protein 70 after ischemia-reperfusion. J Neuroinflammation 2014;11:81. [PMID: 24755298 DOI: 10.1186/1742-2094-11-81] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
364 Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One. 2013;8:e63388. [PMID: 23696823 DOI: 10.1371/journal.pone.0063388] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 20.3] [Reference Citation Analysis]
365 Di Palo DM, Garruti G, Di Ciaula A, Molina-Molina E, Shanmugam H, De Angelis M, Portincasa P. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis. Nutrients 2020;12:E564. [PMID: 32098159 DOI: 10.3390/nu12020564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
366 Czaja MJ. Function of Autophagy in Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2016;61:1304-1313. [PMID: 26725058 DOI: 10.1007/s10620-015-4025-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
367 Barlow GM, Lin EA, Mathur R. An Overview of the Roles of the Gut Microbiome in Obesity and Diabetes. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Elsevier; 2018. pp. 65-91. [DOI: 10.1016/b978-0-12-812019-4.00006-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
368 Lade A, Noon LA, Friedman SL. Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. Curr Opin Oncol 2014;26:100-7. [PMID: 24275855 DOI: 10.1097/CCO.0000000000000042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
369 Miura K, Seki E, Ohnishi H, Brenner DA. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract 2010;2010:362847. [PMID: 21274430 DOI: 10.1155/2010/362847] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 9.0] [Reference Citation Analysis]
370 Bashiardes S, Shapiro H, Rozin S, Shibolet O, Elinav E. Non-alcoholic fatty liver and the gut microbiota. Mol Metab. 2016;5:782-794. [PMID: 27617201 DOI: 10.1016/j.molmet.2016.06.003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 20.2] [Reference Citation Analysis]
371 Bottani M, Cornaghi L, Donetti E, Ferraretto A. Excess of nutrient-induced morphofunctional adaptation and inflammation degree in a Caco2/HT-29 in vitro intestinal co-culture. Nutrition 2019;58:156-66. [PMID: 30419477 DOI: 10.1016/j.nut.2018.07.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
372 Nobili V, Pinzani M. Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. Alcohol Alcohol 2011;46:627-9. [PMID: 21697185 DOI: 10.1093/alcalc/agr074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
373 Guo X, Roberts MR, Becker SM, Podd B, Zhang Y, Chua SC Jr, Myers MG Jr, Duggal P, Houpt ER, Petri WA Jr. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol 2011;4:294-303. [PMID: 21124310 DOI: 10.1038/mi.2010.76] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
374 Genser L, Aguanno D, Soula HA, Dong L, Trystram L, Assmann K, Salem J, Vaillant J, Oppert J, Laugerette F, Michalski M, Wind P, Rousset M, Brot-laroche E, Leturque A, Clément K, Thenet S, Poitou C. Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes: Jejunal permeability in human obesity. J Pathol 2018;246:217-30. [DOI: 10.1002/path.5134] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 16.5] [Reference Citation Analysis]
375 Ellekilde M, Krych L, Hansen CH, Hufeldt MR, Dahl K, Hansen LH, Sørensen SJ, Vogensen FK, Nielsen DS, Hansen AK. Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters. Res Vet Sci. 2014;96:241-250. [PMID: 24556473 DOI: 10.1016/j.rvsc.2014.01.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
376 Kless C, Müller VM, Schüppel VL, Lichtenegger M, Rychlik M, Daniel H, Klingenspor M, Haller D. Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity. Mol Nutr Food Res 2015;59:968-78. [PMID: 25676872 DOI: 10.1002/mnfr.201400840] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
377 Gao J, Gillilland MG 3rd, Owyang C. Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship. Gut Microbes 2014;5:571-5. [PMID: 25244596 DOI: 10.4161/gmic.32130] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
378 Suriano F, Vieira-Silva S, Falony G, Roumain M, Paquot A, Pelicaen R, Régnier M, Delzenne NM, Raes J, Muccioli GG, Van Hul M, Cani PD. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin. Microbiome 2021;9:147. [PMID: 34183063 DOI: 10.1186/s40168-021-01097-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Gnauck A, Lentle RG, Kruger MC. Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci 2016;53:197-215. [PMID: 26732012 DOI: 10.3109/10408363.2015.1123215] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
380 Saad MJ, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology (Bethesda). 2016;31:283-293. [PMID: 27252163 DOI: 10.1152/physiol.00041.2015] [Cited by in Crossref: 169] [Cited by in F6Publishing: 185] [Article Influence: 33.8] [Reference Citation Analysis]
381 Du J, Cao LP, Jia R, Gu Z, He Q, Xu P, Yin G, Ma Y. Alleviative effects of total flavones of Glycyrrhiza uralensis Fisch on oxidative stress and lipid metabolism disorder induced by high-fat diet in intestines of Tilapia (Oreochromis niloticus). 3 Biotech 2021;11:348. [PMID: 34221818 DOI: 10.1007/s13205-021-02785-w] [Reference Citation Analysis]
382 Hur KY, Lee MS. Gut Microbiota and Metabolic Disorders. Diabetes Metab J. 2015;39:198-203. [PMID: 26124989 DOI: 10.4093/dmj.2015.39.3.198] [Cited by in Crossref: 118] [Cited by in F6Publishing: 103] [Article Influence: 16.9] [Reference Citation Analysis]
383 Kanwal S, Aliya S, Xin Y. Anti-Obesity Effect of Dictyophora indusiata Mushroom Polysaccharide (DIP) in High Fat Diet-Induced Obesity via Regulating Inflammatory Cascades and Intestinal Microbiome. Front Endocrinol (Lausanne) 2020;11:558874. [PMID: 33329380 DOI: 10.3389/fendo.2020.558874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
384 Nah G, Park SC, Kim K, Kim S, Park J, Lee S, Won S. Type-2 Diabetics Reduces Spatial Variation of Microbiome Based on Extracellur Vesicles from Gut Microbes across Human Body. Sci Rep 2019;9:20136. [PMID: 31882892 DOI: 10.1038/s41598-019-56662-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
385 Chopyk DM, Grakoui A. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020;159:849-63. [PMID: 32569766 DOI: 10.1053/j.gastro.2020.04.077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
386 Dominique M, Legrand R, Galmiche M, Azhar S, Deroissart C, Guérin C, do Rego JL, Leon F, Nobis S, Lambert G, Lucas N, Déchelotte P. Changes in Microbiota and Bacterial Protein Caseinolytic Peptidase B During Food Restriction in Mice: Relevance for the Onset and Perpetuation of Anorexia Nervosa. Nutrients 2019;11:E2514. [PMID: 31635300 DOI: 10.3390/nu11102514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
387 Arroba AI, Alcalde-Estevez E, García-Ramírez M, Cazzoni D, de la Villa P, Sánchez-Fernández EM, Mellet CO, García Fernández JM, Hernández C, Simó R, Valverde ÁM. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice. Biochim Biophys Acta 2016;1862:1663-74. [PMID: 27267343 DOI: 10.1016/j.bbadis.2016.05.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
388 Zhou AL, Ward RE. Milk polar lipids modulate lipid metabolism, gut permeability, and systemic inflammation in high-fat-fed C57BL/6J ob/ob mice, a model of severe obesity. J Dairy Sci 2019;102:4816-31. [PMID: 30981495 DOI: 10.3168/jds.2018-15949] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
389 Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, Del Vecchio Blanco C, Loguercio C. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 2011;43:431-438. [PMID: 21163715 DOI: 10.1016/j.dld.2010.10.015] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 8.7] [Reference Citation Analysis]
390 Thompson JS, Weseman RA, Rochling FA, Grant WJ, Botha JF, Langnas AN, Mercer DF. Preresection obesity increases the risk of hepatobiliary complications in short bowel syndrome. Nutrients 2012;4:1358-66. [PMID: 23201759 DOI: 10.3390/nu4101358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
391 Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007;47:571-9. [PMID: 17644211 DOI: 10.1016/j.jhep.2007.04.019] [Cited by in Crossref: 421] [Cited by in F6Publishing: 413] [Article Influence: 28.1] [Reference Citation Analysis]
392 Zhang J, Tu M, Liu Z, Zhang G. Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved. Prostaglandins Leukot Essent Fatty Acids 2020;162:102180. [PMID: 33038829 DOI: 10.1016/j.plefa.2020.102180] [Reference Citation Analysis]
393 Shang H, Sun J, Chen YQ. Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice. PLoS One 2016;11:e0154373. [PMID: 27123997 DOI: 10.1371/journal.pone.0154373] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
394 Cândido FG, Valente FX, Grześkowiak ŁM, Moreira APB, Rocha DMUP, Alfenas RCG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr 2018;69:125-43. [PMID: 28675945 DOI: 10.1080/09637486.2017.1343286] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 16.4] [Reference Citation Analysis]
395 Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15. [PMID: 20353583 DOI: 10.1186/1476-9255-7-15] [Cited by in Crossref: 220] [Cited by in F6Publishing: 215] [Article Influence: 18.3] [Reference Citation Analysis]
396 Singh N, Kim HC, Song R, Dhinsa JK, Torres SR, De Jesus M. Candida albicans Elicits Pro-Inflammatory Differential Gene Expression in Intestinal Peyer's Patches. Mycopathologia 2019;184:461-78. [PMID: 31230200 DOI: 10.1007/s11046-019-00349-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
397 Xiao YT, Yan WH, Cao Y, Yan JK, Cai W. P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis. Cell Physiol Biochem 2017;41:623-34. [PMID: 28214831 DOI: 10.1159/000457933] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
398 Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis. 2013;45:543-551. [PMID: 23280158 DOI: 10.1016/j.dld.2012.11.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
399 Lakhan SE, Kirchgessner A. Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med 2011;9:202. [PMID: 22115311 DOI: 10.1186/1479-5876-9-202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
400 de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010;299:G440-8. [PMID: 20508158 DOI: 10.1152/ajpgi.00098.2010] [Cited by in Crossref: 525] [Cited by in F6Publishing: 500] [Article Influence: 43.8] [Reference Citation Analysis]
401 de Medeiros IC, de Lima JG. Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? – A mechanistic hypothesis. Medical Hypotheses 2015;85:148-52. [DOI: 10.1016/j.mehy.2015.04.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
402 Sachithanandan N, Graham KL, Galic S, Honeyman JE, Fynch SL, Hewitt KA, Steinberg GR, Kay TW. Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes 2011;60:2023-31. [PMID: 21646388 DOI: 10.2337/db11-0259] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
403 Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17:67. [PMID: 30819194 DOI: 10.1186/s12967-019-1810-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
404 Biolato M, Manca F, Marrone G, Cefalo C, Racco S, Miggiano GA, Valenza V, Gasbarrini A, Miele L, Grieco A. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(4): 509-520 [PMID: 30700946 DOI: 10.3748/wjg.v25.i4.509] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
405 Zhu Z, Huang Y, Luo X, Wu Q, He J, Li S, Barba FJ. Modulation of lipid metabolism and colonic microbial diversity of high-fat-diet C57BL/6 mice by inulin with different chain lengths. Food Res Int 2019;123:355-63. [PMID: 31284986 DOI: 10.1016/j.foodres.2019.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
406 Margină D, Ungurianu A, Purdel C, Tsoukalas D, Sarandi E, Thanasoula M, Tekos F, Mesnage R, Kouretas D, Tsatsakis A. Chronic Inflammation in the Context of Everyday Life: Dietary Changes as Mitigating Factors. Int J Environ Res Public Health 2020;17:E4135. [PMID: 32531935 DOI: 10.3390/ijerph17114135] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
407 Sasaki GY, Li J, Cichon MJ, Kopec RE, Bruno RS. Catechin‐Rich Green Tea Extract and the Loss‐of‐TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis. Mol Nutr Food Res 2021;65:2000998. [DOI: 10.1002/mnfr.202000998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
408 de Faria Ghetti F, Oliveira DG, de Oliveira JM, de Castro Ferreira LEVV, Cesar DE, Moreira APB. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. Eur J Nutr. 2018;57:861-876. [PMID: 28875318 DOI: 10.1007/s00394-017-1524-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
409 Chen J, Yang Y, Yang Y, Dai Z, Kim IH, Wu G, Wu Z. Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity. J Nutr 2021;151:1769-78. [PMID: 33830211 DOI: 10.1093/jn/nxab058] [Reference Citation Analysis]
410 Sabico S, Al-Mashharawi A, Al-Daghri NM, Yakout S, Alnaami AM, Alokail MS, McTernan PG. Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial. J Transl Med 2017;15:249. [PMID: 29228964 DOI: 10.1186/s12967-017-1354-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
411 Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009;50:90-7. [PMID: 18815435 DOI: 10.1194/jlr.M800156-JLR200] [Cited by in Crossref: 380] [Cited by in F6Publishing: 181] [Article Influence: 27.1] [Reference Citation Analysis]
412 Szulińska M, Łoniewski I, van Hemert S, Sobieska M, Bogdański P. Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial. Nutrients 2018;10:E773. [PMID: 29914095 DOI: 10.3390/nu10060773] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 15.3] [Reference Citation Analysis]
413 Duggal P, Guo X, Haque R, Peterson KM, Ricklefs S, Mondal D, Alam F, Noor Z, Verkerke HP, Marie C, Leduc CA, Chua SC Jr, Myers MG Jr, Leibel RL, Houpt E, Gilchrist CA, Sher A, Porcella SF, Petri WA Jr. A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest 2011;121:1191-8. [PMID: 21393862 DOI: 10.1172/JCI45294] [Cited by in Crossref: 104] [Cited by in F6Publishing: 63] [Article Influence: 9.5] [Reference Citation Analysis]
414 Russo F, Linsalata M, Clemente C, Chiloiro M, Orlando A, Marconi E, Chimienti G, Riezzo G. Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutrition Research 2012;32:940-6. [DOI: 10.1016/j.nutres.2012.09.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
415 Giles DA, Moreno-Fernandez ME, Divanovic S. IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets 2015;16:1315-23. [PMID: 26028039 DOI: 10.2174/1389450116666150531153627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
416 Singer G, Stokes KY, Terao S, Granger DN. SEPSIS-INDUCED INTESTINAL MICROVASCULAR AND INFLAMMATORY RESPONSES IN OBESE MICE. Shock 2009;31:275-9. [DOI: 10.1097/shk.0b013e3181834ab3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
417 Chen J, He X, Huang J. Diet effects in gut microbiome and obesity. J Food Sci 2014;79:R442-51. [PMID: 24621052 DOI: 10.1111/1750-3841.12397] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
418 Castanon N, Luheshi G, Layé S. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci 2015;9:229. [PMID: 26190966 DOI: 10.3389/fnins.2015.00229] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 13.6] [Reference Citation Analysis]
419 Wruck W, Graffmann N, Kawala MA, Adjaye J. Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease. Stem Cells. 2016;35:89-96. [PMID: 27374784 DOI: 10.1002/stem.2454] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
420 Abenavoli L, Milic N, De Lorenzo A, Luzza F. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease. Endocrine. 2013;43:65-67. [PMID: 22740094 DOI: 10.1007/s12020-012-9731-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
421 Li S, Wu WC, He CY, Han Z, Jin DY, Wang L. Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats. World J Gastroenterol 2008; 14(20): 3254-3258 [PMID: 18506935 DOI: 10.3748/wjg.14.3254] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
422 Norris GH, Blesso CN. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation. Nutrients 2017;9:E1180. [PMID: 29143791 DOI: 10.3390/nu9111180] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
423 Huang ZY, Stabler T, Pei FX, Kraus VB. Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthritis Cartilage 2016;24:1769-75. [PMID: 27216281 DOI: 10.1016/j.joca.2016.05.008] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
424 Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol. 2014;36:115-132. [PMID: 24337650 DOI: 10.1007/s00281-013-0404-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
425 Muthuri SG, Zhang W, Maciewicz RA, Muir K, Doherty M. Beer and wine consumption and risk of knee or hip osteoarthritis: a case control study. Arthritis Res Ther 2015;17:23. [PMID: 25652201 DOI: 10.1186/s13075-015-0534-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
426 Dornas W, Lagente V. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacol Res. 2019;141:418-428. [PMID: 30658094 DOI: 10.1016/j.phrs.2019.01.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
427 Sutter AG, Palanisamy AP, Lench JH, Jessmore AP, Chavin KD. Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. Annals of Hepatology 2015;14:735-43. [DOI: 10.1016/s1665-2681(19)30769-0] [Cited by in Crossref: 13] [Article Influence: 1.9] [Reference Citation Analysis]
428 He LX, Zhang ZF, Zhao J, Li L, Xu T, Bin Sun, Ren JW, Liu R, Chen QH, Wang JB, Salem MM, Pettinato G, Zhou JR, Li Y. Ginseng oligopeptides protect against irradiation-induced immune dysfunction and intestinal injury. Sci Rep 2018;8:13916. [PMID: 30224720 DOI: 10.1038/s41598-018-32188-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
429 Stenman LK, Burcelin R, Lahtinen S. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics. Benef Microbes. 2015; Epub ahead of print: 1-12. [PMID: 26565087 DOI: 10.3920/bm2015.0069] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 4.9] [Reference Citation Analysis]
430 Bluemel S, Williams B, Knight R, Schnabl B. Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol 2016;311:G1018-36. [PMID: 27686615 DOI: 10.1152/ajpgi.00245.2016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
431 Cӑtoi AF, Vodnar DC, Corina A, Nikolic D, Citarrella R, Pérez-Martínez P, Rizzo M. Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives. Curr Pharm Des 2019;25:2038-50. [PMID: 31298152 DOI: 10.2174/1381612825666190708190437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
432 Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, da Silva NF, Sabico SL, Kumar S, McTernan PG, Harte AL. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol. 2009;8:20. [PMID: 19368716 DOI: 10.1186/1475-2840-8-20] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
433 Wang M, Li L, Chen Y, Lian G, Wang J, Zhang J, Shan K, Shang L, Tian F, Jing C. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery. Obes Surg 2021;31:327-36. [PMID: 32974816 DOI: 10.1007/s11695-020-04974-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
434 Schwenger KJP, Bolzon CM, Li C, Allard JP. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. Eur J Nutr 2019;58:1771-84. [PMID: 30306296 DOI: 10.1007/s00394-018-1844-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
435 Conroy KP, Davidson IM, Warnock M. Pathogenic obesity and nutraceuticals. Proc Nutr Soc 2011;70:426-38. [PMID: 21854698 DOI: 10.1017/S0029665111001662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
436 Pei R, Martin DA, Dimarco DM, Bolling BW. Evidence for the effects of yogurt on gut health and obesity. Critical Reviews in Food Science and Nutrition 2015;57:1569-83. [DOI: 10.1080/10408398.2014.883356] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
437 Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn's disease? Dig Dis Sci. 2011;56:837-844. [PMID: 21221790 DOI: 10.1007/s10620-010-1541-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
438 Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res. 2013;19:6074-6083. [PMID: 23958744 DOI: 10.1158/1078-0432.ccr-12-2603] [Cited by in Crossref: 191] [Cited by in F6Publishing: 128] [Article Influence: 21.2] [Reference Citation Analysis]
439 Walenbergh SM, Koek GH, Bieghs V, Shiri-Sverdlov R. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatol. 2013;58:801-810. [PMID: 23183522 DOI: 10.1016/j.jhep.2012.11.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
440 Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014; 20(44): 16464-16473 [PMID: 25469014 DOI: 10.3748/wjg.v20.i44.16464] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
441 Hirahatake KM, Bruno RS, Bolling BW, Blesso C, Alexander LM, Adams SH. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health. Adv Nutr 2020;11:266-79. [PMID: 31555799 DOI: 10.1093/advances/nmz105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
442 Schlecht I, Gronwald W, Behrens G, Baumeister SE, Hertel J, Hochrein J, Zacharias HU, Fischer B, Oefner PJ, Leitzmann MF. Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites. PLoS One 2017;12:e0175133. [PMID: 28403191 DOI: 10.1371/journal.pone.0175133] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
443 Yu J, Marsh S, Hu J, Feng W, Wu C. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterol Res Pract. 2016;2016:2862173. [PMID: 27247565 DOI: 10.1155/2016/2862173] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
444 Telle-Hansen VH, Holven KB, Ulven SM. Impact of a Healthy Dietary Pattern on Gut Microbiota and Systemic Inflammation in Humans. Nutrients. 2018;10. [PMID: 30453534 DOI: 10.3390/nu10111783] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
445 Toral M, Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Utrilla MP, Garrido-Mesa N, Rodríguez-Cabezas ME, Olivares M, Gálvez J. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin Sci (Lond). 2014;127:33-45. [PMID: 24410749 DOI: 10.1042/cs20130339] [Cited by in Crossref: 76] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
446 Salamati S, Martins C, Kulseng B. Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects. Clin Obes 2015;5:42-7. [PMID: 25611585 DOI: 10.1111/cob.12079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
447 Amato A, Baldassano S, Mulè F. GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. J Endocrinol 2016;229:R57-66. [PMID: 27048234 DOI: 10.1530/JOE-16-0035] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
448 Capuron L, Lasselin J, Castanon N. Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology 2017;42:115-28. [PMID: 27402495 DOI: 10.1038/npp.2016.123] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 11.5] [Reference Citation Analysis]
449 Xu J, Bourgeois H, Vandermeulen E, Vlaeminck B, Meyer E, Demeyere K, Hesta M. Secreted phospholipase A2 inhibitor modulates fatty acid composition and reduces obesity-induced inflammation in Beagle dogs. Vet J 2015;204:214-9. [PMID: 25920769 DOI: 10.1016/j.tvjl.2015.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
450 Kim JJ, Sears DD. TLR4 and Insulin Resistance. Gastroenterol Res Pract 2010;2010:212563. [PMID: 20814545 DOI: 10.1155/2010/212563] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
451 Duan M, Wang Y, Zhang Q, Zou R, Guo M, Zheng H. Characteristics of gut microbiota in people with obesity. PLoS One 2021;16:e0255446. [PMID: 34375351 DOI: 10.1371/journal.pone.0255446] [Reference Citation Analysis]
452 Ritze Y, Böhle M, Haub S, Hubert A, Enck P, Zipfel S, Bischoff SC. Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice. BMC Gastroenterol 2013;13:169. [PMID: 24321090 DOI: 10.1186/1471-230X-13-169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
453 Shao Q, Wu Y, Ji J, Xu T, Yu Q, Ma C, Liao X, Cheng F, Wang X. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Front Psychiatry 2021;12:711835. [PMID: 34966296 DOI: 10.3389/fpsyt.2021.711835] [Reference Citation Analysis]
454 Brun P, Dean A, Di Marco V, Surajit P, Castagliuolo I, Carta D, Ferlin MG. Peroxisome proliferator-activated receptor-γ mediates the anti-inflammatory effect of 3-hydroxy-4-pyridinecarboxylic acid derivatives: Synthesis and biological evaluation. European Journal of Medicinal Chemistry 2013;62:486-97. [DOI: 10.1016/j.ejmech.2013.01.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
455 Nakano M, Murohisa T, Imai Y, Tamano M, Hiraishi H. Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Gastroenterology Res 2013;6:17-25. [PMID: 27785221 DOI: 10.4021/gr513w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
456 Martínez-Uña M, López-Mancheño Y, Diéguez C, Fernández-Rojo MA, Novelle MG. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. Int J Mol Sci 2020;21:E9368. [PMID: 33316927 DOI: 10.3390/ijms21249368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
457 McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology. 2007;45:1343-1346. [PMID: 17538963 DOI: 10.1002/hep.21788] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
458 Latorre J, Lluch A, Ortega FJ, Gavaldà-Navarro A, Comas F, Morón-Ros S, Rodríguez A, Becerril S, Villarroya F, Frühbeck G, Ricart W, Giralt M, Fernández-Real JM, Moreno-Navarrete JM. Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice. Pharmacol Res 2021;166:105486. [PMID: 33556481 DOI: 10.1016/j.phrs.2021.105486] [Reference Citation Analysis]
459 Zhou Y, Ruan Z, Wen Y, Yang Y, Mi S, Zhou L, Wu X, Ding S, Deng Z, Wu G, Yin Y. Chlorogenic acid from honeysuckle improves hepatic lipid dysregulation and modulates hepatic fatty acid composition in rats with chronic endotoxin infusion. J Clin Biochem Nutr 2016;58:146-55. [PMID: 27013782 DOI: 10.3164/jcbn.14-138] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
460 Joosen AM, Kuhnle GG, Runswick SA, Bingham SA. Urinary sucrose and fructose as biomarkers of sugar consumption: comparison of normal weight and obese volunteers. Int J Obes (Lond) 2008;32:1736-40. [PMID: 18725895 DOI: 10.1038/ijo.2008.145] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
461 Yamazaki H, Kushiyama A, Sakoda H, Fujishiro M, Yamamotoya T, Nakatsu Y, Kikuchi T, Kaneko S, Tanaka H, Asano T. Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages. Mediators Inflamm 2018;2018:3062319. [PMID: 30046278 DOI: 10.1155/2018/3062319] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
462 Pomytkin IA, Cline BH, Anthony DC, Steinbusch HW, Lesch K, Strekalova T. Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance? Behavioural Brain Research 2015;276:111-7. [DOI: 10.1016/j.bbr.2014.04.049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
463 Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol. 2019;70:1278-1291. [PMID: 30797053 DOI: 10.1016/j.jhep.2019.02.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 22.7] [Reference Citation Analysis]
464 Huang Z, Chen J, Li B, Zeng B, Chou CH, Zheng X, Xie J, Li H, Hao Y, Chen G, Pei F, Shen B, Kraus VB, Wei H, Zhou X, Cheng L. Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice. Ann Rheum Dis 2020;79:646-56. [PMID: 32205337 DOI: 10.1136/annrheumdis-2019-216471] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
465 Erridge C. The Roles of Pathogen-Associated Molecular Patterns in Atherosclerosis. Trends in Cardiovascular Medicine 2008;18:52-6. [DOI: 10.1016/j.tcm.2007.12.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
466 Wu H, Wang Y, Li H, Meng L, Zheng N, Wang J. Effect of Food Endotoxin on Infant Health. Toxins (Basel) 2021;13:298. [PMID: 33922125 DOI: 10.3390/toxins13050298] [Reference Citation Analysis]
467 Toral M, Romero M, Rodríguez-Nogales A, Jiménez R, Robles-Vera I, Algieri F, Chueca-Porcuna N, Sánchez M, de la Visitación N, Olivares M, García F, Pérez-Vizcaíno F, Gálvez J, Duarte J. Lactobacillus fermentum Improves Tacrolimus-Induced Hypertension by Restoring Vascular Redox State and Improving eNOS Coupling. Mol Nutr Food Res 2018;:e1800033. [PMID: 29851248 DOI: 10.1002/mnfr.201800033] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
468 Kirpich IA, Marsano LS, McClain CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem. 2015;48:923-930. [PMID: 26151226 DOI: 10.1016/j.clinbiochem.2015.06.023] [Cited by in Crossref: 128] [Cited by in F6Publishing: 132] [Article Influence: 18.3] [Reference Citation Analysis]
469 Lee B, Moon KM, Kim CY. Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals. J Immunol Res 2018;2018:2645465. [PMID: 30648119 DOI: 10.1155/2018/2645465] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 15.5] [Reference Citation Analysis]
470 Gnauck A, Lentle RG, Kruger MC. Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women. Innate Immun 2015;21:537-45. [PMID: 25398227 DOI: 10.1177/1753425914557101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
471 Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86:1286-1292. [PMID: 17991637 DOI: 10.1093/ajcn/86.5.1286] [Cited by in Crossref: 472] [Cited by in F6Publishing: 428] [Article Influence: 31.5] [Reference Citation Analysis]
472 Suriano F, Manca C, Flamand N, Depommier C, Van Hul M, Delzenne NM, Silvestri C, Cani PD, Di Marzo V. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159056. [PMID: 34606993 DOI: 10.1016/j.bbalip.2021.159056] [Reference Citation Analysis]
473 Kim CY, Kim KH. Curcumin prevents leptin-induced tight junction dysfunction in intestinal Caco-2 BBe cells. J Nutr Biochem 2014;25:26-35. [PMID: 24314862 DOI: 10.1016/j.jnutbio.2013.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
474 Abbasi Oshaghi E, Goodarzi MT, Higgins V, Adeli K. Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Critical Reviews in Clinical Laboratory Sciences 2017;54:267-93. [DOI: 10.1080/10408363.2017.1343274] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
475 Cao W, Liu F, Li RW, Yang R, Wang Y, Xue C, Tang Q. Triacylglycerol rich in docosahexaenoic acid regulated appetite via the mediation of leptin and intestinal epithelial functions in high-fat, high-sugar diet-fed mice. J Nutr Biochem 2021;99:108856. [PMID: 34517098 DOI: 10.1016/j.jnutbio.2021.108856] [Reference Citation Analysis]
476 Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol 2014;5:462. [PMID: 25309544 DOI: 10.3389/fimmu.2014.00462] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
477 Tian X, Yu Z, Feng P, Ye Z, Li R, Liu J, Hu J, Kakade A, Liu P, Li X. Lactobacillus plantarum TW1-1 Alleviates Diethylhexylphthalate-Induced Testicular Damage in Mice by Modulating Gut Microbiota and Decreasing Inflammation. Front Cell Infect Microbiol 2019;9:221. [PMID: 31297340 DOI: 10.3389/fcimb.2019.00221] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
478 Massier L, Chakaroun R, Tabei S, Crane A, Didt KD, Fallmann J, von Bergen M, Haange SB, Heyne H, Stumvoll M, Gericke M, Dietrich A, Blüher M, Musat N, Kovacs P. Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes. Gut 2020;69:1796-806. [PMID: 32317332 DOI: 10.1136/gutjnl-2019-320118] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 17.5] [Reference Citation Analysis]
479 Alam S, Mustafa G, Alam M, Ahmad N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World J Gastrointest Pathophysiol. 2016;7:211-217. [PMID: 27190693 DOI: 10.3349/ymj.2016.57.4.885] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
480 Han R, Ma J, Li H. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Front Med. 2018;12:645-657. [PMID: 30178233 DOI: 10.1007/s11684-018-0645-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
481 Bakhshimoghaddam F, Alizadeh M. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. Clin Nutr ESPEN 2021;44:61-8. [PMID: 34330514 DOI: 10.1016/j.clnesp.2021.05.012] [Reference Citation Analysis]
482 Bessac A, Cani PD, Meunier E, Dietrich G, Knauf C. Inflammation and Gut-Brain Axis During Type 2 Diabetes: Focus on the Crosstalk Between Intestinal Immune Cells and Enteric Nervous System. Front Neurosci 2018;12:725. [PMID: 30364179 DOI: 10.3389/fnins.2018.00725] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
483 Curtis KS, McCracken K, Espinosa E, Ong J, Buck DJ, Davis RL. Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats. Neurochem Res 2018;43:1802-13. [PMID: 30030770 DOI: 10.1007/s11064-018-2596-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
484 Guerville M, Leroy A, Sinquin A, Laugerette F, Michalski M, Boudry G. Western-diet consumption induces alteration of barrier function mechanisms in the ileum that correlates with metabolic endotoxemia in rats. American Journal of Physiology-Endocrinology and Metabolism 2017;313:E107-20. [DOI: 10.1152/ajpendo.00372.2016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
485 Fiorentino TV, Succurro E, Arturi F, Giancotti A, Peronace C, Quirino A, Sesti F, Andreozzi F, Hribal ML, Perticone F, Focà A, Sesti G. Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study. Sci Rep 2018;8:13616. [PMID: 30206293 DOI: 10.1038/s41598-018-32108-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
486 Piringer P, Buder R, Firlinger F, Kapral C, Luft C, Sega W, Wewalka F, Lenz K. Steatohepatitis und Leberzirrhose: Erstmanifestation 23 Jahre nach ejunoilealem Bypass. Wien Klin Wochenschr 2007;119:733-8. [DOI: 10.1007/s00508-007-0850-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
487 Torres-fuentes C, Schellekens H, Dinan TG, Cryan JF. A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review. Nutritional Neuroscience 2014;18:49-65. [DOI: 10.1179/1476830513y.0000000099] [Cited by in Crossref: 81] [Cited by in F6Publishing: 31] [Article Influence: 10.1] [Reference Citation Analysis]
488 Lindenberg FCB, Ellekilde M, Thörn AC, Kihl P, Larsen CS, Hansen CHF, Metzdorff SB, Aalbæk B, Hansen AK. Dietary LPS traces influences disease expression of the diet-induced obese mouse. Res Vet Sci 2019;123:195-203. [PMID: 30682583 DOI: 10.1016/j.rvsc.2019.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
489 Marques C, Fernandes I, Meireles M, Faria A, Spencer JPE, Mateus N, Calhau C. Gut microbiota modulation accounts for the neuroprotective properties of anthocyanins. Sci Rep 2018;8:11341. [PMID: 30054537 DOI: 10.1038/s41598-018-29744-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
490 Iino C, Endo T, Mikami K, Hasegawa T, Kimura M, Sawada N, Nakaji S, Fukuda S. Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. Hepatol Int 2019;13:748-56. [DOI: 10.1007/s12072-019-09987-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
491 Jin R, Willment A, Patel SS, Sun X, Song M, Mannery YO, Kosters A, McClain CJ, Vos MB. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. Int J Hepatol. 2014;2014:560620. [PMID: 25328713 DOI: 10.1155/2014/560620] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
492 Power SE, O’Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr. 2014;111:387-402. [PMID: 23931069 DOI: 10.1017/s0007114513002560] [Cited by in Crossref: 245] [Cited by in F6Publishing: 117] [Article Influence: 27.2] [Reference Citation Analysis]
493 Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, Sabico S, O'Hare JP, Ceriello A, Saravanan P, Kumar S, McTernan PG. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 2012;35:375-82. [PMID: 22210577 DOI: 10.2337/dc11-1593] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
494 Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10:729-734. [PMID: 18089955 DOI: 10.1097/mco.0b013e3282efdebb] [Cited by in Crossref: 200] [Cited by in F6Publishing: 88] [Article Influence: 14.3] [Reference Citation Analysis]
495 Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28 Suppl 1:38-42. [PMID: 23855294 DOI: 10.1111/jgh.12019] [Cited by in Crossref: 147] [Cited by in F6Publishing: 150] [Article Influence: 18.4] [Reference Citation Analysis]
496 Verdam FJ, Greve JW, Roosta S, van Eijk H, Bouvy N, Buurman WA, Rensen SS. Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab. 2011;96:E379-E383. [PMID: 21084402 DOI: 10.1210/jc.2010-1333] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
497 Zhou Z, Kim JW, Qi J, Eo SK, Lim CW, Kim B. Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon β-Modulated IL-1 Receptor Antagonist in Mice. Am J Pathol 2020;190:614-29. [PMID: 31972159 DOI: 10.1016/j.ajpath.2019.11.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
498 El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol 2020;13:403-21. [PMID: 32308061 DOI: 10.1080/17512433.2020.1758063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
499 Blevins CH, Sharma AN, Johnson ML, Geno D, Gupta M, Bharucha AE, Katzka DA, Iyer PG. Influence of reflux and central obesity on intercellular space diameter of esophageal squamous epithelium. United European Gastroenterol J 2016;4:177-83. [PMID: 27087944 DOI: 10.1177/2050640615598426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
500 Sim S, Hibberd ML. Caenorhabditis elegans susceptibility to gut Enterococcus faecalis infection is associated with fat metabolism and epithelial junction integrity. BMC Microbiol 2016;16:6. [PMID: 26769134 DOI: 10.1186/s12866-016-0624-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
501 Mularczyk M, Bourebaba Y, Kowalczuk A, Marycz K, Bourebaba L. Probiotics-rich emulsion improves insulin signalling in Palmitate/Oleate-challenged human hepatocarcinoma cells through the modulation of Fetuin-A/TLR4-JNK-NF-κB pathway. Biomed Pharmacother 2021;139:111560. [PMID: 33839491 DOI: 10.1016/j.biopha.2021.111560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
502 Vanni E, Bugianesi E. The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? Hepatology. 2009;49:1790-1792. [PMID: 19475679 DOI: 10.1002/hep.23036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
503 Ávila PRM, Michels M, Vuolo F, Bilésimo R, Burger H, Milioli MVM, Sonai B, Borges H, Carneiro C, Abatti M, Santana IVV, Michelon C, Dal-pizzol F. Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora. Nutrition 2020;73:110727. [DOI: 10.1016/j.nut.2020.110727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
504 Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(23): 7381-7391 [PMID: 24966608 DOI: 10.3748/wjg.v20.i23.7381] [Cited by in CrossRef: 182] [Cited by in F6Publishing: 160] [Article Influence: 22.8] [Reference Citation Analysis]
505 Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int. 2008;28:1026-1033. [PMID: 18397235 DOI: 10.1111/j.1478-3231.2008.01723.x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 139] [Article Influence: 9.9] [Reference Citation Analysis]
506 Erridge C. Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. Atherosclerosis. 2011;216:1-6. [PMID: 21439567 DOI: 10.1016/j.atherosclerosis.2011.02.043] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
507 Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
508 Sundekilde UK, Yde CC, Honore AH, Caverly Rae JM, Burns FR, Mukerji P, Mawn MP, Stenman L, Dragan Y, Glover K, Jensen HM. An Integrated Multi-Omics Analysis Defines Key Pathway Alterations in a Diet-Induced Obesity Mouse Model. Metabolites 2020;10:E80. [PMID: 32106514 DOI: 10.3390/metabo10030080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
509 Wu Y, Jiang Z, Zheng C, Wang L, Zhu C, Yang X, Wen X, Ma X. Effects of protein sources and levels in antibiotic-free diets on diarrhea, intestinal morphology, and expression of tight junctions in weaned piglets. Anim Nutr 2015;1:170-6. [PMID: 29767171 DOI: 10.1016/j.aninu.2015.08.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
510 Raybould HE. Gut microbiota, epithelial function and derangements in obesity. J Physiol 2012;590:441-6. [PMID: 22183718 DOI: 10.1113/jphysiol.2011.222133] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
511 Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 2010;4:659-672. [PMID: 21286336 DOI: 10.1007/s12072-010-9219-x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 147] [Article Influence: 12.3] [Reference Citation Analysis]
512 Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho ML, Linros J, Apter D, Scheinin M, Kloster Smerud H, Rissanen A, Lahtinen S. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine 2016;13:190-200. [PMID: 27810310 DOI: 10.1016/j.ebiom.2016.10.036] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
513 Ducheix S, Vegliante MC, Villani G, Napoli N, Sabbà C, Moschetta A. Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β. Cell Mol Life Sci 2016;73:3809-22. [PMID: 27522544 DOI: 10.1007/s00018-016-2331-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
514 Alexandre A. Suggested involvement of ketone bodies in the pathogenesis of the metabolic syndrome. Med Hypotheses 2013;80:578-81. [PMID: 23466063 DOI: 10.1016/j.mehy.2013.01.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
515 Yang K, Zhu J, Wu J, Zhong Y, Shen X, Petrov B, Cai W. Maternal Vitamin D Deficiency Increases Intestinal Permeability and Programs Wnt/β-Catenin Pathway in BALB/C Mice. JPEN J Parenter Enteral Nutr 2021;45:102-14. [PMID: 32270535 DOI: 10.1002/jpen.1820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
516 Panwar S, Sharma S, Tripathi P. Role of Barrier Integrity and Dysfunctions in Maintaining the Healthy Gut and Their Health Outcomes. Front Physiol 2021;12:715611. [PMID: 34630140 DOI: 10.3389/fphys.2021.715611] [Reference Citation Analysis]
517 Ho-Plagaro A, Santiago-Fernandez C, Rodríguez-Díaz C, Lopez-Gómez C, Garcia-Serrano S, Rodríguez-Pacheco F, Valdes S, Rodríguez-Cañete A, Alcaín-Martínez G, Ruiz-Santana N, Vázquez-Pedreño L, García-Fuentes E. Different Expression of Duodenal Genes Related to Insulin Resistance Between Nonobese Women and Those with Severe Obesity. Obesity (Silver Spring) 2020;28:1708-17. [PMID: 32729246 DOI: 10.1002/oby.22902] [Reference Citation Analysis]
518 Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635-645. [PMID: 22560216 DOI: 10.1016/j.cmet.2012.04.001] [Cited by in Crossref: 491] [Cited by in F6Publishing: 473] [Article Influence: 49.1] [Reference Citation Analysis]
519 Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7:e37160. [PMID: 22629362 DOI: 10.1371/journal.pone.0037160] [Cited by in Crossref: 142] [Cited by in F6Publishing: 137] [Article Influence: 14.2] [Reference Citation Analysis]
520 Zhang M, Zhang YH, Fu HQ, Zhang QM, Wang TL. Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation. Front Pharmacol 2018;9:1007. [PMID: 30356711 DOI: 10.3389/fphar.2018.01007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
521 Ye C, Wang R, Wang M, Huang Z, Tang C. Leptin alleviates intestinal mucosal barrier injury and inflammation in obese mice with acute pancreatitis. Int J Obes (Lond) 2018;42:1471-9. [PMID: 29934609 DOI: 10.1038/s41366-018-0125-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
522 Amin R, Asplin J, Jung D, Bashir M, Alshaikh A, Ratakonda S, Sharma S, Jeon S, Granja I, Matern D, Hassan H. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria. Kidney Int 2018;93:1098-107. [PMID: 29395336 DOI: 10.1016/j.kint.2017.11.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
523 Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Katano Y, Goto H. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. Biochemical and Biophysical Research Communications 2016;470:15-21. [DOI: 10.1016/j.bbrc.2015.12.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
524 He K, Chan CB, Liu X, Jia Y, Luo HR, France SA, Liu Y, Wilson WD, Ye K. Identification of a molecular activator for insulin receptor with potent anti-diabetic effects. J Biol Chem 2011;286:37379-88. [PMID: 21908618 DOI: 10.1074/jbc.M111.247387] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
525 Chistiakov DA, Bobryshev YV, Kozarov E, Sobenin IA, Orekhov AN. Role of gut microbiota in the modulation of atherosclerosis-associated immune response. Front Microbiol 2015;6:671. [PMID: 26175728 DOI: 10.3389/fmicb.2015.00671] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
526 Zhu L, Sha L, Li K, Wang Z, Wang T, Li Y, Liu P, Dong X, Dong Y, Zhang X, Wang H. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats. Lipids Health Dis 2020;19:20. [PMID: 32028957 DOI: 10.1186/s12944-019-1167-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
527 Battson ML, Lee DM, Weir TL, Gentile CL. The gut microbiota as a novel regulator of cardiovascular function and disease. J Nutr Biochem 2018;56:1-15. [PMID: 29427903 DOI: 10.1016/j.jnutbio.2017.12.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 13.2] [Reference Citation Analysis]
528 He LX, Wang JB, Sun B, Zhao J, Li L, Xu T, Li H, Sun JQ, Ren J, Liu R, Chen QH, Zhang ZF, Li Y. Suppression of TNF-α and free radicals reduces systematic inflammatory and metabolic disorders: Radioprotective effects of ginseng oligopeptides on intestinal barrier function and antioxidant defense. J Nutr Biochem 2017;40:53-61. [PMID: 27863345 DOI: 10.1016/j.jnutbio.2016.09.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
529 Hao W, Hao C, Wu C, Xu Y, Jin C. Aluminum induced intestinal dysfunction via mechanical, immune, chemical and biological barriers. Chemosphere 2021;288:132556. [PMID: 34648793 DOI: 10.1016/j.chemosphere.2021.132556] [Reference Citation Analysis]
530 Mehal WZ. The Gordian Knot of dysbiosis, obesity and NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10:637-644. [PMID: 23958600 DOI: 10.1038/nrgastro.2013.146] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 11.2] [Reference Citation Analysis]
531 Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012;108:801-809. [PMID: 22717075 DOI: 10.1017/s0007114512001213] [Cited by in Crossref: 330] [Cited by in F6Publishing: 175] [Article Influence: 33.0] [Reference Citation Analysis]
532 Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Molecular Aspects of Medicine 2013;34:39-58. [DOI: 10.1016/j.mam.2012.11.001] [Cited by in Crossref: 314] [Cited by in F6Publishing: 289] [Article Influence: 34.9] [Reference Citation Analysis]
533 Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, Wang C, Geng X, Li B. Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: Inflammatory and oxidative stress playing important roles. Journal of Ethnopharmacology 2019;239:111910. [DOI: 10.1016/j.jep.2019.111910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
534 Pevsner-Fischer M, Tuganbaev T, Meijer M, Zhang SH, Zeng ZR, Chen MH, Elinav E. Role of the microbiome in non-gastrointestinal cancers. World J Clin Oncol 2016; 7(2): 200-213 [PMID: 27081642 DOI: 10.5306/wjco.v7.i2.200] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
535 Cai J, Liu J, Fan P, Dong X, Zhu K, Liu X, Zhang N, Cao Y. Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation. Int Immunopharmacol 2021;99:108015. [PMID: 34339962 DOI: 10.1016/j.intimp.2021.108015] [Reference Citation Analysis]
536 Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab 2015;21:369-78. [PMID: 25662404 DOI: 10.1016/j.cmet.2015.01.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 116] [Article Influence: 20.0] [Reference Citation Analysis]
537 Mohammad S, Thiemermann C. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front Immunol 2020;11:594150. [PMID: 33505393 DOI: 10.3389/fimmu.2020.594150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
538 Reinhardt C, Reigstad CS, Bäckhed F. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009;48:249-56. [PMID: 19271298 DOI: 10.1097/mpg.0b013e318183187c] [Cited by in Crossref: 117] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
539 Nascimento JC, Matheus VA, Oliveira RB, Tada SFS, Collares-Buzato CB. High-Fat Diet Induces Disruption of the Tight Junction-Mediated Paracellular Barrier in the Proximal Small Intestine Before the Onset of Type 2 Diabetes and Endotoxemia. Dig Dis Sci 2021;66:3359-74. [PMID: 33104937 DOI: 10.1007/s10620-020-06664-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
540 Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biol 2018;15:467-79. [PMID: 29413959 DOI: 10.1016/j.redox.2018.01.009] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 20.3] [Reference Citation Analysis]
541 Çolakoğlu M, Xue J, Trajkovski M. Bacteriophage Prevents Alcoholic Liver Disease. Cell 2020;180:218-20. [PMID: 31978341 DOI: 10.1016/j.cell.2019.12.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
542 Jia X, Iwanowycz S, Wang J, Saaoud F, Yu F, Wang Y, Hu J, Chatterjee S, Wang Q, Fan D. Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Exp Biol Med (Maywood) 2014;239:1025-35. [PMID: 24740873 DOI: 10.1177/1535370214530247] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
543 Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 2012; 18(9): 923-929 [PMID: 22408351 DOI: 10.3748/wjg.v18.i9.923] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 87] [Article Influence: 9.2] [Reference Citation Analysis]
544 Martin IV, Schmitt J, Minkenberg A, Mertens JC, Stieger B, Mullhaupt B, Geier A. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biol Chem. 2010;391:1441-1449. [PMID: 20868235 DOI: 10.1515/bc.2010.141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
545 Zhang DM, Jiao RQ, Kong LD. High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions. Nutrients. 2017;9:335. [PMID: 28353649 DOI: 10.3390/nu9040335] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 14.6] [Reference Citation Analysis]